Podcasts about global collaboration

Presented by SmartStop Self Storage, this week's episode of SheEO Lead-In, we listen to our host, Rebecca Jones, engaging in a thought-provoking discussion with Edna Patricia Hernandez, Market Expansion and Binational Affairs for ITJ USA, Inc.Patricia discusses her role in fostering cross-border business collaboration between the U.S. and Mexico. ITJ specializes in nearshoring talent solutions, engineering, R&D, cybersecurity, AI, and software development, particularly in the pharma, healthcare, and biotechnology sectors. She highlights the benefits of nearshoring, including client confidentiality, IP protection under the USMCA agreement, and the proximity to major U.S. markets. Patricia emphasized the importance of being a connector, leveraging her extensive experience in international business and logistics to facilitate technological and commercial exchanges. She also shared her personal journey and advice for young women aspiring to similar careers.We want to thank our incredible sponsor, SmartStop Self Storage, a leader in self storage real estate, and a company that upholds its core principles of leading together, embracing change and enhancing everyone's journey. To learn more about SmartStop, please visit SmartStop Self Storage. Thank you for being a part of the SheEO Lead-In community!  Please be sure to share our episodes and subscribe to this storage vault of wisdom and knowledge, built by women and for women.

Dr. Robert Soiffer took an interest in medicine at an early age when he played a physician in his first-grade play.  Today, he is a leading physician, researcher, and teacher at Dana-Farber Cancer Institute, a world leader in oncology.  In this episode, Dr. Soiffer describes the incredible pace of change in the field of cancer research and treatment and the detection tools and cures that are right around the corner.  He also reflects on how he maintains a positive and optimistic outlook despite the many times he's forced to deliver terrible news to patients and families.  While he tries hard not to bring these tough times home with him, he also stresses the importance of keeping his humanity and treating his patients and their families as people, not just statistics.     Chapters:  02:29 Dana-Farber's Special Mission  Dr. Soiffer discusses what makes Dana-Farber Cancer Institute unique, emphasizing its focus on cancer patients and the common purpose among all staff.   05:50 Evolution of Cancer Treatment  This segment details the seismic shift in cancer treatment over the past 40 years, from nonspecific chemotherapy to targeted therapies focusing on specific mutations.   10:25 Bone Marrow Transplants and Graft vs. Leukemia  Dr. Soiffer delves into the history of bone marrow transplants, highlighting the Nobel Prize-winning work of E. Donald Thomas and the intriguing concept of graft versus leukemia effect.   15:02 The Role of Medical Education and Mentoring  This chapter emphasizes the critical role of medical education and mentoring in shaping the future of medicine, drawing from Dr. Soiffer's experience as chief medical resident and mentor. He discusses the mutual learning process between experienced physicians and younger generations, and the importance of continuous learning.  19:50 Personal Impact of Oncology Work  Dr. Soiffer reflects on the emotional challenges of his work, balancing optimism with realism and honesty while treating patients facing life-threatening situations. He discusses the difficulty of compartmentalizing emotions and the importance of maintaining humanity and connection with patients and their families, even when outcomes are not positive.  24:57 The Value of Clinical Trials  This chapter explains the critical role of clinical trials in advancing cancer treatment, from early-stage phase I trials to comparative studies. Dr. Soiffer describes patients participating in these trials as brave pioneers, highlighting how targeted, immune, and cellular therapies would not exist without their contributions.  28:39 Global Collaboration in Medicine  Dr. Soiffer discusses the extensive global collaboration in medical and scientific fields, emphasizing the shared mission to develop therapies for suffering patients.   35:33 Future of Cancer Treatment and Prevention  Looking ahead, Dr. Soiffer predicts less toxic and more precise cancer treatments with improved therapeutic ratios, focusing on overcoming resistance and early detection. He discusses the potential of preventing progression to full-blown malignancy through early intervention and the growing understanding of germline predispositions to cancer.  41:26 Conclusion and Call to Optimism  The episode concludes with Bill Burke thanking Dr. Soiffer for his time and invaluable insights, highlighting the rapid pace of change and innovation in cancer research. He also expresses hope and optimism for the future of cancer care. 

Lucie and David discuss the origins and evolution of Farmer Research Networks (FRNs) within the work of the Global Collaboration for Resilient Food Systems. They explore how FRNs were conceived as a way to combine participatory research with large-scale data and reflect on ongoing debates around embedded scaling, participation, and the distinction between FRNs and approaches such as Participatory Action Research (PAR). The conversation highlights both the promise and the practical challenges of building research systems that are deeply contextual while capable of generating broader learning and impact.

In this episode of DriveTime, Robert Roos, president and CEO of the Pronto Network, as well as president of NEXUS North America, and Thierry Mugnier, the co-founder and chief finance and innovation officer at Nexus Automotive International, discuss the Nexus Business Forum in Lausanne, Switzerland, and the growing importance of global collaboration across the automotive aftermarket.The event brought together hundreds of leaders from around the world, including a larger-than-usual North American presence, allowing distributors and manufacturers to build relationships, compare market challenges and prepare for the future of vehicle service.

Episode 1 of Rethinking EHS, Season 3 reflects on 25 years of the Inogen Alliance, highlighting how its success has been built on connecting global organisations with deep local expertise to tackle complex environmental, health, safety, and sustainability challenges.  The discussion underscores key lessons for organisations: prioritise local knowledge, embrace technology, and foster strong partnerships to deliver meaningful, scalable impact, ultimately demonstrating that sustainable progress depends on aligning global ambition with on-the-ground realities. -------------- 00:00 – Intro  00:03 – Opening & Series Introduction  01:13 – Setting the Scene: Topics & Guests  01:43 – The Origin Story: Why the Alliance Was Created  03:15 – Rising Complexity: Regulation & Local Expertise  05:43 – Why an Alliance Model (Not Expansion)?  07:21 – Evolution Over 25 Years  09:49 – Key Moments: When the Model Proved Itself  16:32 – The Present: Strategy, Purpose & Growth  22:09 – The Future: Risk, Uncertainty & Opportunity  31:52 – Advice & Closing Reflections  -------------  Sponsor  Rethinking EHS is brought to you by the Inogen Alliance. Inogen Alliance is a global network of 70+ companies providing environment, health, safety and sustainability services working together to provide one point of contact to guide multinational organizations to meet their global commitments locally. Visit http://www.inogenalliance.com/podcast to learn more. -------------  Links  https://www.Inogenalliance.com/resources https://www.Inogenalliance.com/podcast Angelique on LinkedIn: https://www.linkedin.com/in/angeliquedickson Alex on LinkedIn: https://www.linkedin.com/in/alex-ferguson-1a40b511 Keith on LinkedIn: https://www.linkedin.com/in/keith-knoke-27587a7 Produced by https://www.madcontent.co.nz

As proposals for the future Horizon Europe are scrutinised by the European Parliament, we discuss likely changes to the seven-year funding programme and whether it can support a coalition of like-minded powers amidst the current geopolitical upheaval. The next version of Horizon Europe, due to launch in 2028, is likely to show much greater alignment with EU economic and defence priorities, backed by the budget almost doubling to €175bn a year. The initial proposal put forward by the European Commission opens Horizon up to dual purpose and defence focused research and places more weight on research designed to drive EU competitiveness in key industries such as green energy and digital technologies. This week Miranda Prynne is joined by THE features editor Paul Jump to discuss how the planned changes could affect European research and the impact on Horizon's flourishing global network of non-EU members such as the UK, Canada and Japan whose contributions currently make up around a third of Horizon's total budget. Listen to Paul's take on whether the new Horizon Europe will provide a platform for a stronger international network of like-minded middle powers, giving them more clout on the world stage, or if a closer focus on Europe's needs will create tensions with non-EU members.

What does a missing jar of marmalade in India reveal about global leadership?You might be surprised.In this episode of Build a Vibrant Culture, Nicole Greer sits down with cross-cultural business expert Dean Foster, author of Business Beyond Borders, to explore what he's learned from working in more than 100 countries. From communication styles and time management to risk tolerance, information sharing, and workplace formality, Dean shares powerful stories that reveal how culture quietly shapes everything we do at work.If you lead a global team, work across time zones, or collaborate with people from different backgrounds — this conversation will expand your awareness and sharpen your leadership.Vibrant Highlights:[00:12:50] The Missing Marmalade StoryDean shares how ordering a croissant in India turned into a masterclass on indirect communication and hierarchy — and what it means for leaders managing global teams.[00:20:13] Direct vs. Indirect CulturesWhy Americans “say what they mean,” why some cultures don't — and how misreading this can create serious workplace breakdowns.[00:23:19] Managing the Clock Across CulturesFrom strict deadlines to flexible time norms, Dean explains how history, climate, and agriculture shaped how cultures view punctuality and planning.[00:32:04] Information Sharing & Risk ToleranceSome cultures share everything. Others guard information as power. Dean explains how this connects to decision-making and comfort with risk.[00:54:51] The #1 Rule for Working Anywhere in the WorldDean's final advice after decades of global consulting: Stay humble. You're a guest — and leadership means adapting, not imposing.Connect with Dean:Book: Business Beyond Borders https://a.co/d/0eKdRaryOther books by Dean: bit.ly/4aNXar9Website: deanfosterglobal.comLinkedIn: linkedin.com/dfainterculturalYouTube: youtube.com/deanfosterglobalIG: @deanfosterglobalPodcast: oopscultureshow.blubrry.netReady to build a culture where people feel valued, energized, and committed?Bring Nicole Greer, The Vibrant Coach, to your leadership team, organization, or conference to ignite clarity, accountability, energy, and results.Visit: vibrantculture.comEmail: nicole@vibrantculture.comWatch Nicole's TEDx Talk: vibrantculture.com/videos

As Holocaust remembrance increasingly moves into digital spaces shaped by artificial intelligence, virtual worlds and interactive media, experts are calling for stronger global coordination to ensure ethical, sustainable and responsible memory work.Speaking at UN Headquarters around International Holocaust Remembrance Day, Professor Victoria Grace Richardson-Walden stressed that no single institution or sector can address these challenges alone. Policymakers, technology companies, museums, educators, researchers and digital creators must work together, she said, to avoid fragmented efforts that waste resources and risk losing vital historical material as technologies rapidly evolve.UN News's Ana Carmo started by asking her why global collaboration is key for shaping the future of Holocaust memory in digital spaces. 

This episode is brought to you by HalloCasa, the SEO-ranked digital business card for real estate agents. Looking to find the right agent, no matter where you are?Visit https://home.hallocasa.com to discover and connect with top real estate agents globally.In Episode 246 of the HalloCasa Podcast, I sit down with Farook Mahmood FRICS, former World President (2017–18) of FIABCI International Real Estate Federation and President of FIABCI-India, to explore the present and future of India's real estate market and its growing role on the global stage.With over three decades of leadership in real estate, Farook shares deep insights into India's tier 2 and tier 3 cities, long-term investment strategies, and how international collaboration and professional associations like FIABCI are shaping global real estate standards.We also discuss what it takes to succeed as a real estate professional today, from working directly with developers to building credibility, ethics, and long-term trust in the industry.Episode Chapters00:02:00 Status of the Indian real estate market00:03:00 Growth of tier 2 and tier 3 cities in India00:05:00 India as an international real estate investment opportunity00:08:00 Global collaboration and Farook's international influence00:13:00 Silverline Realty's long-term investment strategy00:16:00 Tips for real estate investors in India00:22:00 Working directly with real estate developers00:24:00 Evolution of the global real estate market & role of associations00:30:00 Professionalism in Indian real estate00:33:00 Advice for aspiring real estate agents00:40:00 Conclusion & final thoughtsYou can contact Farook via:https://silverlinerealty.com/https://www.linkedin.com/in/farook-mahmood-frics-3a9729b/

Lucie and David discuss their recent workshops in Niger, Burkina Faso, and Mali, focusing on teaching effective research visualizations to diverse stakeholders within the Global Collaboration for Resilient Food Systems. They highlight the importance of visual storytelling, the challenges faced, and the inspiring engagement of local teams.

In today's episode of Game Over: c*ncer, we explore one of the greatest superpowers in pediatric cancer research: collaboration. From co-funding grants to global scientific networks, teamwork is driving lifesaving breakthroughs, especially for the rarest and hardest-to-treat childhood cancers.Hosted by Val Solomon (Director of Program Impact) and Dana Nichols (Executive Director of CKc), this episode features an inspiring conversation with Dr. Anirban Das, a pediatric neuro-oncologist and cancer geneticist at SickKids Hospital in Toronto and assistant professor at the University of Toronto.Dr. Das is a 2024 Cannonball Kids' Cancer Young Investigator, a grant co-funded with Kindred Foundation, supporting his groundbreaking work on DNA replication repair deficiency and central nervous system tumors. His research not only spans advanced biology and immunotherapy but also reaches families across the world, including low- and middle-income countries, through the International Replication Repair Deficiency Consortium, which now includes more than 50 countries.What We Cover in This Episode:How Dr. Das unexpectedly found his path into pediatric neuro-oncologyWhy early-career funding (like CKc Young Investigator grants) is critical to innovationHow collaboration between foundations accelerates research for rare cancersThe global consortium bringing efficiency, shared data, and evidence-based care to families worldwideWhat makes replication repair deficiency tumors unique, and why they were once considered “rare”The reality of the research pipeline: grant writing, mentorship, and the challenges young investigators faceHow CKc and Kindred partnered to fuel the next generation of cancer breakthroughsWhy teamwork is not just helpful in pediatric cancer, it's essentialIf this conversation moves you, please like, comment, and share to help us educate for change. Leaving a review helps more families find tangible hope.To learn more about Kindred Foundation, visit www.kindredfoundation.caTune in to hear this inspiring and informative conversation. Don't forget to subscribe, leave a review, and join the fight to make Game Over: c*ncer a reality.----------------------------------Connect with Dana: https://www.linkedin.com/in/danaknichols/Connect with Val: https://www.linkedin.com/in/valerie-solomon/Upcoming Ckc Events: https://cannonballkidscancer.org/category/make-an-impact/events/----------------------------------Podcast Produced by Hi Hello Labs: Website: https://www.hihellolabs.com/

Educators often assume that clubs, activities, and school culture must happen in person—that building belonging in virtual learning is limited or even impossible. Many imagine distance learners as isolated kids behind screens, missing the social experiences that shape identity, leadership, and community.But what if that assumption is simply wrong?In this conversation, Cindy Carbajal, a 20-year veteran of Pearson Virtual Schools, shows us how vibrant, student-driven communities thrive online through thoughtful structure, flexible engagement pathways, and opportunities for real agency.Cindy oversees a global clubs and activities program serving 11,000+ students across time zones, grade levels, and cultural backgrounds. Her work demonstrates that:1. Student-Centered Design Fuels Real BelongingClubs are built with a goal that at least 50% of live time is student talk time—not passive listening.Students share, present, lead, and create—driving engagement and ownership.Broad-topic clubs (like Art Club instead of Crochet Club) help students discover unexpected interests and communities.2. Flexible Models Match Virtual Students' Real LivesEvery offering includes both synchronous and asynchronous pathways, ensuring access regardless of schedules, time zones, or family obligations.Live sessions build community; asynchronous challenges deepen skills and allow for self-paced exploration.3. Clubs Quietly Reinforce Academic & Durable SkillsCindy calls it “stealth learning”:Math skills reinforced in esports strategies.Reading skills strengthened through participation logistics and peer review.Executive functioning, digital communication, and leadership built through planning, presenting, and collaborating.4. Data Drives Program EvolutionHer team measures:Enrollment and attendanceStudent and caregiver satisfactionWithdrawal trendsOverlap between global clubs and local school clubs These insights help fine-tune offerings and spark new opportunities—like peer tutoring, reading buddies, and esports leagues.How Educators Can Apply These Insights Today1. Start with the student experience—not the content.Ask: Where can students lead? Where can they share? How can this be theirs?2. Build broad entry points.Instead of a niche club for each interest, create umbrellas where kids can explore together.3. Don't replicate in-person school—capitalize on what's uniquely possible online.Global reach, time-zone diversity, virtual volunteer opportunities, and student leadership that scales across schools—these are advantages brick-and-mortar can't match.4. Teach students how to interact online.Cindy's programs explicitly teach:How to give feedback in writing and art clubsHow to share space respectfullyHow to show kindness online (Kindness Club!)5. Track what matters.Attendance, satisfaction, enrollment, and student stories help shape future offerings.Episode LinksPearson Virtual Schools — Learn more about their virtual school network and programs, including Cindy's Global Clubs.Host LinksDiscover more virtual learning opportunities at CILC.org with hosts Tami Moehring and Allyson Mitchell.Seth Fleischauer's Banyan Global Learning provides meaningful global learning experiences that prepare students across the globe for success in an interconnected world.

      Imagine navigating the complexities of wartime medicine, where every decision can mean the difference between life and death. Join us for an unfiltered conversation with Dr. Oleksandr Sokolov, a Ukrainian vascular surgeon who has been in the thick of it, bringing groundbreaking innovations to the surgical battlefield. Dr. Sokolov reveals how the use of acellular tissue-engineered vessels is not just a technical advancement, but a lifeline for those caught in the crossfire. Get a firsthand account of how these innovations are reshaping trauma management in ways that remain largely unseen by the rest of the world.     We shine a spotlight on how advanced vascular implants are making waves in combat zones, offering hope where traditional methods have faltered. Dr. Sokolov shares the striking successes of a bioengineered vascular prosthesis that is defying expectations with its high patency rate and promise of limb salvage. These tissue-engineered vessels are not just keeping soldiers and civilians alive, but are setting a new standard for what's possible in extreme surgical conditions. The potential of these technologies to transform future medical care, from pediatric surgeries to cardiac bypasses, is nothing short of revolutionary.      But amidst the technological triumphs, there is also profound human resilience. Dr. Sokolov's stories are not only about scientific breakthroughs but also about the enduring spirit of those affected by war. As we discuss the critical role of global humanitarian networks, the conversation turns to the power of collaboration and the peace-driven future we all hope for. This episode is a testament to courage, innovation, and the relentless pursuit of better patient outcomes—even in the harshest of environments.   Chapters: (00:04) Vascular Surgery in a War Zone (11:10) Advanced Vascular Implants in Combat (24:26) Enhancing Survival With Engineered Vessels (36:56) Lessons in Combat Medicine and Technology   Chapter Summaries: (00:04) Vascular Surgery in a War Zone Dr. Sokolov shares his experiences providing surgical care in war-torn Ukraine, highlighting the use of acellular tissue-engineered vessels and the collapse of the military medical system.   (11:10) Advanced Vascular Implants in Combat Nature's bioengineered vascular prosthesis offers advantages in military medicine, with high success rates and reduced surgery time.   (24:26) Enhancing Survival With Engineered Vessels Battlefield trauma surgery, engineered vessels, managing risks, and potential applications in pediatric and cardiac cases.   (36:56) Lessons in Combat Medicine and Technology Dr. Sokolov shares lessons from wartime surgery, collaboration with Humacyte, advancements in vascular surgery technology, and hope for peace.   Take Home Messages: Wartime Innovation in Medicine: The episode highlights the transformative impact of acellular tissue-engineered vessels in wartime trauma care, demonstrating how these bioengineered solutions are enhancing surgical outcomes, particularly in conflict zones where traditional methods may not suffice. Global Collaboration and Support: It underscores the vital role of global humanitarian aid and international collaboration in advancing medical care in conflict areas. This support network provides essential resources and fosters the sharing of expertise, crucial for improving patient outcomes amidst challenging conditions. Resilience and Courage in Healthcare: Through powerful narratives, the episode captures the resilience of medical professionals and patients operating in high-stakes environments. These stories emphasize the human spirit's ability to persevere and adapt, even when faced with the dire circumstances of war. Broader Applications of Bioengineered Vessels: The discussion extends beyond immediate trauma care, exploring the potential applications of these advanced vascular implants in pediatric surgery and cardiac procedures, hinting at a broader revolution in vascular health care. The Importance of Medical System Support: The episode advocates for robust system support over reliance on individual heroics, stressing the need for organized and sustainable medical frameworks to effectively manage and respond to the healthcare challenges posed by war.   Episode Keywords: Wartime medicine, vascular surgery, Ukraine conflict, Dr. Oleksandr Sokolov, bioengineered vessels, trauma care, humanitarian aid, military medical systems, acellular tissue-engineered vessels, limb salvage, infection prevention, combat zone surgery, Humacyte collaboration, pediatric surgery, cardiac procedures, medical innovation, frontline surgeons, global medical community, medical advancements, survival and resilience   Hashtags: #WartimeMedicine #VascularInnovation #UkraineSurgeons #HumanitarianAid #BioengineeredVessels #TraumaCare #MedicalBreakthroughs #ConflictZoneMedicine #AdvancedSurgery #HealingAmidstWar   Honoring the Legacy and Preserving the History of Military Medicine The WarDocs Mission is to honor the legacy, preserve the oral history, and showcase career opportunities, unique expeditionary experiences, and achievements of Military Medicine. We foster patriotism and pride in Who we are, What we do, and, most importantly, How we serve Our Patients, the DoD, and Our Nation.   Find out more and join Team WarDocs at https://www.wardocspodcast.com/ Check our list of previous guest episodes at https://www.wardocspodcast.com/our-guests Subscribe and Like our Videos on our YouTube Channel: https://www.youtube.com/@wardocspodcast Listen to the “What We Are For” Episode 47. https://bit.ly/3r87Afm   WarDocs- The Military Medicine Podcast is a Non-Profit, Tax-exempt-501(c)(3) Veteran Run Organization run by volunteers. All donations are tax-deductible and go to honoring and preserving the history, experiences, successes, and lessons learned in Military Medicine. A tax receipt will be sent to you. WARDOCS documents the experiences, contributions, and innovations of all military medicine Services, ranks, and Corps who are affectionately called "Docs" as a sign of respect, trust, and confidence on and off the battlefield,demonstrating dedication to the medical care of fellow comrades in arms.     Follow Us on Social Media Twitter: @wardocspodcast Facebook: WarDocs Podcast Instagram: @wardocspodcast LinkedIn: WarDocs-The Military Medicine Podcast YouTube Channel: https://www.youtube.com/@wardocspodcast

Share your Field Stories!Welcome back to Environmental Professionals Radio, Connecting the Environmental Professionals Community Through Conversation, with your hosts Laura Thorne and Nic Frederick! On today's episode, we talk with Josh Hirten, Environmental Discipline Leader at CDM Smith about The Silver Tsunami, Mentorship, and Global Collaboration.   Read his full bio below.Help us continue to create great content! If you'd like to sponsor a future episode hit the support podcast button or visit www.environmentalprofessionalsradio.com/sponsor-form Showtimes: 1:39 - Diving Adventures with Nic & Laura8:30 - Interview with Josh Hirten Starts13:34- Sampling through cavern diving 22:04 - Impact of professional organization 29:05 - Field Notes with Josh!Please be sure to ✔️subscribe, ⭐rate and ✍review. This podcast is produced by the National Association of Environmental Professions (NAEP). Check out all the NAEP has to offer at NAEP.org.Connect with Joshua Hirten at https://www.linkedin.com/in/joshua-hirten-pg-22940/Guest  Bio:Joshua Hirten, PG is an Environmental Discipline Leader at CDM Smith with over 28 years of experience. He holds an MS in Geology from the University of Florida, BA in Geology from the State University of New York, Buffalo, and is registered Professional Geologist in Florida.Josh is part of the Sky Wave at CDM Smith Team that combines data acquisition and machine learning to obtain detailed results to drive data to decisions. Josh is the Program Manager for the Waste Cleanup Program at the FDEP. In addition to environmental projects, Josh developed and conducted Project Management training at over 20 locations globally.Josh is actively involved in professional activities, serving as Board Member for National Association of Environmental Professionals and Vice President for Florida Association of Environmental Professionals.Music CreditsIntro: Givin Me Eyes by Grace MesaOutro: Never Ending Soul Groove by Mattijs MullerSupport the showThanks for listening! A new episode drops every Friday. Like, share, subscribe, and/or sponsor to help support the continuation of the show. You can find us on Twitter, Facebook, YouTube, and all your favorite podcast players.

Join us on November 6th, 2025, for the third annual Coast Summit, as we celebrate the visionary leaders who are pioneering solutions to some of the most pressing challenges of our time.This year's theme, "Healthy People, Healthy Planet," highlights the vital link between personal well-being and environmental regeneration. The Coast Summit brings together leaders from the worlds of sustainability, adventure, business, wellness, and storytelling in a format that blends the energy of a trade show with the insight of a summit.This isn't just a gathering—it's a launchpad for people and ideas that are shaping the future.Tickets are limited and expected to sell out quickly! Schedule coming soon!Link here to sign uphttps://www.coastfilmfestival.com/coast-summitJoin us in Utrecht this November 10-12! Link here to sign up https://www.packagingsummit.earth/2025SummaryIn this conversation, Cory Connors and Tom Pollock discuss the mission and impact of GreenBlue and its initiatives in sustainable packaging. They explore the importance of strategic partnerships, the consumer-centric approach of the How to Recycle label, and the significance of global collaboration in addressing sustainability challenges. The upcoming Sustainable Packaging Summit is highlighted as a key event for networking and learning from international practices in packaging innovation.TakeawaysGreenBlue is the parent organization for sustainable packaging initiatives.The Sustainable Packaging Coalition has grown from 75 to over 600 members.Consumer education is crucial for effective recycling practices.Strategic partnerships enhance the impact of sustainability efforts.Global collaboration is essential for addressing packaging challenges.The How to Recycle label simplifies recycling for consumers.Events like the Sustainable Packaging Summit foster valuable relationships.Learning from international practices can improve local sustainability efforts.Innovation in packaging materials is vital for sustainability.Communication and collaboration are key to achieving sustainability goals.TitlesExploring GreenBlue's Mission in Sustainable PackagingThe Importance of Strategic Partnerships in SustainabilitySound bites"We work through our members""We can move faster by working together""We can learn so much from people in Europe"Chapters00:00 Introduction to GreenBlue and Sustainable Packaging Coalition02:40 The Role of Strategic Partnerships in Sustainability05:14 How to Recycle Label: Impact and Collaboration07:57 Global Reach: Expanding GreenBlue's Influence10:41 Sustainable Packaging Summit: Building Relationships13:11 Learning from Global Innovations in Packaging15:56 Who Should Attend the Sustainable Packaging Summit?18:41 Conclusion and Future CollaborationsKeywordsGreenBlue, Sustainable Packaging, How to Recycle, Strategic Partnerships, Global Collaboration, Sustainable Packaging Summit, Consumer Education, Recycling, Packaging Innovation, Environmental Sustainabilityhttps://www.linkedin.com/in/cory-connors/I'm here to help you make your packaging more sustainable! Reach out today and I'll get back to you asap. This podcast is an independent production and the podcast production is an original work of the author. All rights of ownership and reproduction are retained—copyright 2022.

In this episode, Aidan speaks with Carmel King, Partner at Grant Thornton UK, about the role of insolvency practitioners and liquidators in recovering assets lost to fraud and financial crime, especially in the context of digital assets. They discuss how these powers work alongside law enforcement efforts and why collaboration, trust, and clear communication between the public and private sectors are key to delivering better outcomes for victims. Want to go deeper? Join our upcoming webinar, ‘Closing the Asset Recovery Gap', on 14th October at 2pm UK | 9am EDT, where former law enforcement professionals draw on their cross-sector experience to explore how civil recovery routes work alongside law enforcement and how specialised technology platforms are strengthening coordination across sectors. Timestamps00:00 – Introduction and Background 04:00 – The Hidden Powers of Liquidators 09:00 – Bridging Public and Private Sector Efforts 16:00 – Real-World Cases & Lessons Learned 24:00 – Tackling Law Enforcement & Victim Challenges 30:00 – Crypto Recovery: Success Stories & Civil Routes 38:00 – Navigating Jurisdictional & Valuation Hurdles 45:00 – The Future of Asset Recovery & Collaboration About our Guest Carmel King is a Partner at Grant Thornton UK, where she leads the digital asset recovery team. With extensive experience in insolvency and asset recovery, Carmel specialises in combating financial crime and recovering assets for victims. Her work often involves collaboration with law enforcement and private sector professionals to navigate the complexities of cross-border asset recovery and the evolving landscape of crypto assets.Key Takeaways Insolvency as a Recovery Tool: Insolvency and liquidation powers provide a unique mechanism to recover assets lost to fraud, complementing traditional law enforcement efforts. Collaboration Between Public and Private Sectors: Effective asset recovery relies on coordination between law enforcement, investigators, and private practitioners to overcome legal, technical, and operational challenges. Digital Asset Challenges: Cryptocurrencies and other digital assets introduce new complexities, requiring specialised approaches to trace, value, and recover funds. Preventing Re‑Victimisation: Awareness and education are critical to protect victims from fraudulent recovery schemes and ensure fair outcomes. Evolving Landscape of Asset Recovery: Case studies and ongoing developments illustrate how the field is constantly changing, highlighting the importance of innovation, technology, and co‑operation. Resources Mentioned Crypto Fraud and Asset Recovery Network (CFAAR) Grant Thornton UK Met Police | Two people convicted following world's largest crypto seizure Stay Connected Dive deeper into the world of asset recovery by subscribing to Seize & Desist.Disclaimer Our podcasts are for informational purposes only. They are not intended to provide legal, tax, financial, and/or investment advice. Listeners must consult their own advisors before making decisions on the topics discussed. Asset Reality has no responsibility or liability for any decision made or any other acts or omissions in connection with your use of this material. The views expressed by guests are their own and their appearance on the program does not imply an endorsement of them or any entity they represent. Views and opinions expressed by Asset Reality employees are those of the employees and do not necessarily reflect the views of the company. Asset Reality does not guarantee or warrant the accuracy, completeness, timeliness, suitability or validity of the information in any particular podcast and will not be responsible for any claim attributable to errors, omissions, or other inaccuracies of any part of such material. Unless stated otherwise, reference to any specific product or entity does not constitute an endorsement or recommendation by Asset Reality.

In this episode, we discuss knowledge exchange between the Arctic and the Hindu-Kush Himalaya. The conversation emphasizes two-way interactions between the regions, and stresses the need for an interdisciplinary network of scholars to study both their commonalities and differences.Moderating the session was Kamrul Hossain, Research Professor at the Arctic Centre of the University of Lapland.This conversation was recorded live at the Arctic Circle India Forum, held in New Delhi on May 3–4, 2025, and is part of the Polar Dialogue.Arctic Circle is the largest network of international dialogue and cooperation on the future of the Arctic. It is an open democratic platform with participation from governments, organizations, corporations, universities, think tanks, environmental associations, Indigenous communities, concerned citizens, and others interested in the development of the Arctic and its consequences for the future of the globe. It is a nonprofit and nonpartisan organization. Learn more about Arctic Circle at www.ArcticCircle.org or contact us at secretariat@arcticcircle.orgTWITTER:@_Arctic_CircleFACEBOOK:The Arctic CircleINSTAGRAM:arctic_circle_org

Sarah Aswegan, a seasoned biopharma leader and strategic advisor for global rare disease solutions, shares her journey from sales in pharma to her consulting work today. She discusses her experience in transitioning biopharma companies from clinical to commercial success, the evolution of medtech in diagnosing and managing rare diseases, and the collaborative efforts required to bring innovative treatments to market. She also shares insights on current trends in gene therapy, the dynamics of funding, and the importance of data in advancing care for rare disease patients. Guest links: www.saraaswegan.com  Charity supported:  Interested in being a guest on the show or have feedback to share? Email us at theleadingdifference@velentium.com.  PRODUCTION CREDITS Host & Editor: Lindsey Dinneen Producer: Velentium Medical   EPISODE TRANSCRIPT Episode 065 - Sara Aswegan [00:00:00] Lindsey Dinneen: Hi, I'm Lindsey and I'm talking with MedTech industry leaders on how they change lives for a better world. [00:00:09] Diane Bouis: The inventions and technologies are fascinating and so are the people who work with them. [00:00:15] Frank Jaskulke: There was a period of time where I realized, fundamentally, my job was to go hang out with really smart people that are saving lives and then do work that would help them save more lives. [00:00:28] Diane Bouis: I got into the business to save lives and it is incredibly motivating to work with people who are in that same business, saving or improving lives. [00:00:38] Duane Mancini: What better industry than where I get to wake up every day and just save people's lives. [00:00:42] Lindsey Dinneen: These are extraordinary people doing extraordinary work, and this is The Leading Difference. Hello and welcome back to another episode of The Leading Difference podcast. I'm your host Lindsey, and today I'm delighted to welcome to the show, Sarah Aswegan. Sarah is a seasoned biopharma leader helping organizations transition and grow from clinical to commercial success. She prides herself on the success of leading multiple global cross-functional teams and contributing to the success of the franchise areas she oversaw and served. Until recently, she's applied these experiences while serving in a consultancy capacity for many small to midsize biotechs entering or expanding in rare disease. She has also successfully helped organizations to start and scale adjacent spaces to biopharma, and most recently has been serving as a Global Head of Commercial Assets, Brands, and Care Solutions, and has led transformational change at UCP, having been part of the design and scale of the business unit for rare disease. She maintains a strong network among clinicians, access, bioethicists, and patient advocacy globally. Well, thank you so much for joining us today. I'm so excited to speak with you. [00:01:52] Sara Aswegan: Thanks, Lindsey. It's nice to be here. [00:01:54] Lindsey Dinneen: Wonderful. Well, I'd love, if you wouldn't mind, sharing a little bit about yourself and your background and what led you to medtech. [00:02:02] Sara Aswegan: Yeah, thanks Lindsey. You know, I, I started my career ages ago in the pharma side of things, and as my career has grown, so has the exposure across pharmaceuticals, into biotech and including aspects of medtech. As we look at some of the areas I've spent the last 18 years in rare disease, the medtech component is coming in largely around if we think about the diagnosis component and then the management of the different conditions over the lifespan of a child or adult affected by a rare condition. You can see things really evolving. I started my career on the sales side of things. My education is in business and communication, so anyone can learn the science if you have good mentors and people to help you along the way. And I was really, really fortunate to work amongst a team of amazing individuals, both in the US and then now having lived away for about 15 years outside of the US that have helped open my eyes to what can be possible and the differences by markets. And as I mentioned, I spent the last 18 years in the rare disease space really helping companies of all sizes build out and scale their teams, bringing in new assets and bringing solutions to the field of rare disease. And it's something I'm very passionate about. [00:03:06] Lindsey Dinneen: Yeah. Well, thank you for sharing a little bit about that. So I'm curious, that's a very specific niche and I would love to understand how you arrived at that and how you realized, "Oh, this is what I'm meant to be doing." [00:03:19] Sara Aswegan: Yeah. So I made a move geographically and company-wise to a small firm at the time. We were just a very small team. We called it the bootstrapping team at Shire Human Genetic Therapies, and I moved from the Chicago area to Boston, and that was my first really exposure to rare diseases. And, it's a completely different field and it continues to evolve even to this day. But the closeness and proximity you have to patients and their families and those with unmet need. And I have, you know, a couple of close friends as well as a family member that's been affected by a rare disease. So as you're seeking care and support for them, it's not always about the medications. It's about that total person and thinking really holistically about the individual and their care teams that are impacted by those conditions. So the external community we were serving really drove me and introduced me to something that I've stayed with, and it brings great passion to try to find ways to support individuals in our western society, but also looking at low middle income countries and helping facilitate diagnosis to treatment to, again, that whole supportive care and largely from the internal teams within the organizations I've worked with has just is been tremendously rewarding and also equally challenging. It's beautiful to see progress. I mentioned diagnosis and. One of the areas I worked in initially was in the lysosomal storage disease area. And it's the age-old question on diagnosis. Do you facilitate newborn screening, for example, so when your child is born, you have a heel prick done and you can do a series of tests depending on the state you live in, and in some countries in Europe it's also provided. But if there's not a therapy, is it okay to do that type of diagnosis support. And so that challenge, you know, in seeing the policy evolve on a state by state basis. When I began in the rare disease space and MPS Type Two Hunter Syndrome, it's a condition that affects mostly boys and a very small part of our population. We knew we could do newborn screening and there was a therapy available, but it wasn't only realized until a few years ago to introduce newborn screening to help those families at the point of birth to know if their child was affected, and therefore start a different trajectory on how they planned for care for them and plan for if there was a medication or other supportive tools and resources available for them. So it's been extremely dynamic to see how things have evolved. And then now as you see medical and pharma medical technology advance as well into gene therapies. You're seeing news about gene therapy and it's a one time treatment and then the individual hopefully will not have be re redos in their lifetime. Along with that come challenges on that diagnosis piece to make sure they're eligible for the gene therapy. So again, through the device and technology sector, it plays a key role. In addition to the supportive care that goes on for some of these really severe conditions, people have some pretty dynamic needs and it's great to see how things are progressing, but it's still as equally as frustrating, whether you're on the manufacturer side or the family side, to see things be kind of slow sometimes. [00:06:15] Lindsey Dinneen: Yeah, of course. And you're dealing with a specific situation where many times-- please correct me if I'm wrong-- but it seems like many times there's these kinds of studies and conditions are not funded very well in terms of finding solutions to the problem. So how is that something that you, well, first of all, of course we're in a very interesting season of life right now. So how are you seeing funding evolve over the years for these different diseases that are a little bit more rare, and what can we all do in terms of even just awareness and understanding? [00:06:51] Sara Aswegan: Yeah, so that's a huge question. We could probably have about five conversations on this just to scratch the surface, Lindsey. I think if I reflect on the question on what we've seen around funding, I mean there are some wonderful, supportive grants available for the brilliant scientists we have around the world that have a curiosity. So making sure we can facilitate that ongoing academic environment to explore and test the hypothesis. And one of the things that you see coming along, and it's not really around-- I won't think about funding as just pure financial-- but it's the funding of the smarts that go around the table. You see a lot more collaboration amongst academia, industry governments coming together to help build and scale so that there's an awareness and understanding of a condition. I mean, a pediatrician could go through their entire career and never see a boy with Hunter Syndrome. It's just that rare. At the same time, and on the converse of that, if you're working in an industry where you do have access to more funds, the introduction of AI and looking at how we look at drug targeting, drug target selection, genetics and precision medicine have come along quite leaps and bounds in the last several years, but we're still not quite there. But you're seeing advancements with the different cell and gene therapies, having that precision medicine as an option. It's coming forward. The challenge is the size of studies are normally very small because the population is small. So thinking about patient recruitment, how can we help facilitate better identification of individuals that may be out there and not have received diagnosis because of the rarity of the condition? So looking at technology and advancement of integrated electronic health records up to and including, how do we look at the trial designs? And how do manufacturers, academics, industry, and agencies work together to think a little differently around even designing clinical endpoints for the studies that really are meaningful, that will make a difference. And how do you balance that, right? Correct risk benefit conversation, in the spirit of doing no harm. But if there's one chance and there's something available, how do you do that? And coming all the way downstream. If you think about where the organizations have advanced their thinking, their approach, and put funds behind, it's also that ongoing care of the individuals. If you look at the upstream, the types of tests that are available. It could be cancer, it could be the area I am so passionate about in genetic disorders, but it can also be thinking about the workflows that come into play in helping facilitate consistency of care across state borders, across country borders. It's a key piece that are really advancing in real time, but we're still trying to overcome the hurdles that are real. And that's things around data privacy. How do we navigate that in a really meaningful way with the right ethics and integrity. If we think about the regulators, this isn't a huge anti-infective or cardiac study that's ongoing, that there are gonna be tens of thousands of people. So how can we think a little bit differently on advancing the care. In the area I'm working in, Lindsey, especially with some of these individuals that are kids, if they don't get access to care by a certain age point, their window of treatment has closed. And so what could we do to help facilitate earlier diagnosis and then that advanced care. And so I think we can see a lot of really good intentions, and I think the most beautiful thing is even the collective gathering of different patient organizations that have a shared interest of a disease coming together and also helping raise research funds to help support the scientists that have a hypothesis on something that may really make a difference and may matter. [00:10:21] Lindsey Dinneen: Yeah. Yeah. Okay, so, there has been so much innovation in the last few years-- of course, even before that, but it seems to be extremely exciting in the last few years-- especially things like CRISPR and all sorts of new technologies emerging. What are some of the exciting trends that you're seeing in this space specifically that give you hope as you continue to look forward and look for solutions? [00:10:45] Sara Aswegan: I think for me, I mentioned, I touched on it lightly. I think it's that collective, that collaboration and the openness now. The FDA has advanced the way that they think and engage with agencies as well as industry partners. And so what I mean by that, Lindsey, is they're not just engaging with the scientists or with the manufacturers, the drug developers. They're also bringing patients in. And so that collaborative environment, they're even beginning conversations when there's discussion on clinical trial design to understand what really matters. Is it a six minute walk test or is it something around real behavioral or other abilities that can be learned and retained over time that help benefit the quality of life? If you're not gonna be able to cure something, what's really important at that patient front to help facilitate something meaningful. So I think that type of conversation also with the agencies looking at, there was an amazing session held in Europe recently in the mucopolysaccharidosis or the lysosomal storage disease area, looking at advancements of science and saying, can we look at biomarkers alone and create that relationship and understanding there is a clinically meaningful impact if we can address this biomarker. And so, companies like Ultragenyx have really pushed to have that conversation and dialogue and have a drug filed now that's under review based on biomarker endpoints alone, where five years ago, you would never have imagined that being possible. [00:12:12] Lindsey Dinneen: Yeah. Yeah. You touched on something that I would really love to explore a little bit deeper, and that is, when there's a situation that right now we don't have a cure for this disease-- and, you know, obviously we're still working towards it-- but if we don't have a cure, but we are trying to improve the quality of life, how do you balance that in your specific field in terms of: obviously you want the patients to live the best quality of life that they can while balancing so many other, and I don't mean this in a callous way at all, just from a practical perspective, balancing all of these other considerations and things that are also desiring funding and all those competing priorities. So how do you balance that? How, how does that come into play? [00:12:57] Sara Aswegan: So that's a big one. It's a tough one. And I'll oversimplify it and just say data. And what I mean by that, Lindsey is really looking at, with the technology at our fingertips, regardless of the geography you're living in, there's a lot of meaningful information that can be captured. And it's not, again, around one aspect of a disease, but it's the totality of health. So really looking at what could be possible in capturing, is it around energy levels, activity levels. And you'll see that oftentimes in play with the gene therapy, for example, when it's administered, you may have up to 15 years of follow up that you're capturing specific data points. But even in advance of a drug approval, and an area I am also equally passionate about, is access to unlicensed medicines for individuals that can't travel to a clinical trial site and could benefit from an investigational therapy, how do we do that with the right balance in place? And part of that is data and having the willingness of a participant or family member to be so consented in and participating in the study for their child to share that data and share that real world data or real world evidence so that you can measure back and show what impact that drug or treatment or intervention has been having on the individual. So I think it's around that and figuring out how we can overcome some of the complexities and challenges that are real. Not everyone has electronic health records. There's still lots of paper-based offices out there. But in the meantime, there's a lot of advancements in technology. So how do you appropriately use that, that it's also not overburdensome for the individual, for the family as well, that you're doing what really matters and measuring back and having the right conversations with the individuals affected, the investigators, the clinicians, but then the regulators, and going back and sharing why this can be something to help substantiate. It's not your standard phase 1, 2, 3 clinical trial design. That's, yes, there's rigor, but it's a different way of looking at using data to help us advance our understanding of a disease and what's needed by the individual affected. [00:14:53] Lindsey Dinneen: Yeah. So, so when you're speaking with these families and or-- well, first of all, let me actually back up. Do you have direct communication with some of these families and patients that you're working with? [00:15:04] Sara Aswegan: Yes. [00:15:05] Lindsey Dinneen: Yeah. And so when that happens, how. How is it for you? I mean, this is such a challenging area that you have devoted your life to and to, and I'm so impressed with that. And, you're doing the work that's helping save lives and make a difference. But that must be really challenging from a personal level to have these difficult conversations. So how do you balance that as a practitioner and somebody who's desiring to help, but you also have this real life compassion and human being that you're trying to help? [00:15:38] Sara Aswegan: It's tough and it's tremendously rewarding. At the same time, I have so many patient stories I can share with you of meeting them and meeting 'em where they are. I made a trip to Sao Paulo, Brazil once, Lindsey, and met a family that were living in the favelas there, and their aim was to help raise awareness for Hunter's Syndrome because their son had been undiagnosed. They knew something was wrong. He was nonverbal. He had some physical presentation that you could understand. There was something going on, but the technology wasn't there for them. The access to the care center wasn't there for them to get a diagnosis. They were taking buses for hours to different clinics to figure out what's wrong with our son. And he finally received a diagnosis of Hunter Syndrome and they wanted to share the photos because kids with Hunter Syndrome do have some different dysmorphism. So there's something that's strange. They have a bossy forehead, or their bridge of their nose is a little different. Their bellies might be a little bit bigger. So if you start looking at all of these different clues and putting it together, you might suspect and go-- there's other things going on, for sure. So I'm oversimplifying this. However, getting a diagnosis for him by just raising awareness to other families of the physical presentation and what their experience was extremely meaningful for them. And on balance, a family in Florida that I met and their son was diagnosed at age 18 months because their grandmother had seen a program on Mystery Diagnosis and said, "That sounds like my grandson." And so creating the conversation and meeting people where they are is really important because you may have some individuals that are very aware of how drugs are developed and all of the rigor that goes through that to then others that just they don't understand that some drugs are intended for a specific indication, specific population, and helping explain why their child may not be eligible for a particular study. It's tough, and that's not my responsibility, but the clinical teams and the clinicians that are having those conversations. So it's listening and really coming with a open heart and mind and having empathy to help figure out how can you educate. It's even moving into gene therapy. What does gene therapy actually mean? What are the risks? I'm afraid this sounds like it's something so futuristic. What will this mean for my son or daughter in 10 years from now? And, we may not have all of the answers, but you know, science has advanced and it's that risk benefit that you have to exercise. But really it's that coming with compassion and a listening ear and understanding and being honest. And if I can't help, maybe there's someone else that can help or there's a, did you know, there's a clinic here or a center there and helping that network stay connected and thrive is really important. And also being their voice, Lindsey, I mean, we can, we have an opportunity on our pharma, biomedtech side of the world that we can share what we've observed and try to apply that as we come to work every day and think about that family we met in Brazil or in Boston or in Florida or in, you know, Frankfurt, and whatever they may be experiencing. So it's being their advocate in other areas as well. [00:18:34] Lindsey Dinneen: Yeah, exactly. So with what you deal with, I am wondering what kinds of misconceptions or myths do you often encounter that are interesting and yet you would prefer to correct so that those of us in the general population are more informed? [00:18:52] Sara Aswegan: That's a good one. So I think having worked in the rare disease space, one of the biggest scrutinies there, there's on two sides of the coin. One is around diagnosis and why we can't do more around diagnosis. And sometimes the science is just not there yet. So again, to some of these experiences, like the story of the family in Brazil, it may not be about a blood test. It may be about a physical appearance and helping people piece things together. I think on the other end is at the point of delivery of the diagnosis and then if there is a treatment or intervention that can be taken, and not everyone has the same principle in their heart. There are companies that are motivated for different reasons, but certainly the big topic is are around drug prices, whether it's a gene therapy or a chronic lifetime medication, of how do we navigate that and how do we navigate that in a better way? And I think we have to start looking as an industry, as a community of people, of how do we address that? The cost of doing a clinical trial is tremendous. It's hugely expensive. Does it warrant though huge price tags on drugs forever in perpetuity? What's that right balance? And I think having a level of social responsibility and looking at alternatives. And so imagine if we could reduce the time for clinical studies for requirements because we're able to look at other data. Things like the biomarker approach and the follow on real world data that could be captured, could that help us in the total overall offering and the cost to the overall health system? Maybe. I think that as an industry, every company operates with different principles and wanting to do best for the patient community. Some are more profit driven than others, and so that's a reality, and it's one that I get so often at dinners with friends or in personal conversations, professional conversations, and it's a tough one. At the same time, a study of 60 individuals could be double digit millions of dollars. Just the cost of facilitating the study, the production costs of some of these highly technical compounds of different therapies also becomes a factor. So you have to put all these pieces together and really explore what's driving that. [00:20:57] Lindsey Dinneen: Yeah, of course. And yes, I'm sure that's a really difficult conversation to have too, when you're especially working directly with patients and trying to explain all of that and that's a lot. That's a challenge. [00:21:10] Sara Aswegan: Yeah. Yeah. [00:21:11] Lindsey Dinneen: But on the flip side, you know, of course the work that you do makes a huge impact, and I'm wondering if there are any stories that come to mind that just really reinforced to you, "You know what? I am in the right place at the right time, in the right industry." [00:21:25] Sara Aswegan: Absolutely. And I think it goes to, I touched on it very briefly, and there are people that aren't living in near major cities, near major medical centers, and that should not make them obsolete from receiving the best care. And there are two things that have happened and partly because of the pandemic, but also partly because of the willingness to educate and have that connected community amongst clinicians, is around that access to unlicensed medicine and finding pathways that it's not just because a doctor says your son or daughter needs this medication. I'm going to reach out to the manufacturer to see if I can get access because they're not near a clinical trial site or they don't wanna participate, or they're unable to participate in a study. But finding means to do that. And there have been some really creative ways that clinicians have been able to do that, of setting up qualified treatment centers where the individual can go to receive the treatment and then that continuity of care is provided then over the life of their disease. It's something that's become real and meaningful, and you would be shocked at the number of individuals around the world that are receiving access to medicines that normally might have only 10 years ago been available if you were living in the Western Europe or the United States because studies weren't conducted in their country and so there's no pathway for access that is all changing. Those dynamics are changing. It takes a team of people, though. It takes regulators, it takes lawmakers, it takes industry. It takes our logistics teams to be sure if something's stored at cold chain, that that product is delivered in the right context at the right time, just in time for that patient to receive it. So it's a complex challenge, but it's one that we've seen serve individuals in a really meaningful way. And without that, they wouldn't have, they wouldn't have another option. [00:23:11] Lindsey Dinneen: Yeah. So having that impact and just being able to reinforce in those moments of maybe when it's especially difficult or you're especially frustrated like, "Oh my gosh, I wish I could help X, Y, and Z," at least you can look back and go, "Yes, but look at all this that we are doing." [00:23:26] Sara Aswegan: You know, Lindsey, also it's that education piece and being curious and asking questions. The scientific community and one of the lead leaders in the NPS community is in North Carolina, Joe Munzer. Dr. Joe Munzer, he's brilliant. And one of the initiatives that we started was something called a masterclass. And so with Dr. Munzer and seven or eight other clinicians from around the world, we literally went on an educational program around the world. And some of the individuals that had just come out of their postgraduate work, pediatric geneticists or neurologists meeting the number one or two people that know this space so well, being mentored by them. And now those individuals are facilitating their class, the same type of class in their local language to their local communities and creating that level of education and awareness. I mean, it's just to see that real impact over time. I actually get goosebumps just thinking back on the impact that has had. And you've got a community of clinicians that they're, I mean, there's a lot of needs still to study medical genetics. And so hopefully we have individuals that are scientifically interested and will continue that that journey so that they can be the next teachers across borders. That makes the difference. [00:24:37] Lindsey Dinneen: Yeah. Absolutely. Wow. Yeah. Thank you for sharing that. I was also getting goosebumps just listening to it because that's incredible ripple effect that you had and continue to have. That's amazing. [00:24:47] Sara Aswegan: Yeah. Yeah. [00:24:47] Lindsey Dinneen: Yeah. Oh man. Okay. Well, I could talk about this for a long time, but pivoting the conversation a little bit, just for fun. Imagine that you were to be offered a million dollars to teach masterclass on anything you want. It can be within your industry, but doesn't have to be. What would you choose to teach? [00:25:05] Sara Aswegan: Wow. That is a great question, Lindsey. A masterclass-- a million dollars-- a masterclass on anything I would want. I would be drawn to some of the advancements we're seeing in gene therapies, but I think that would be, I wanna try to serve a broader population. Do you know? I think it's, I think if I could look, I would do something around looking back on some of these, if you will use cases and best practices, to share those learnings, just because we know the impact that it will have and has had and continues to have. And not just on the scientific community, but it ripples down into the patient communities of asking that question of "what can be possible, how can we together." Instead of " no," it's actually, "yes and" or "no and" we hear something else, another construct. And really breaking it down to really enforce what I've talked about on several moments during our conversation today is it can't just be the manufacturer, the, or the developer. It can't just be academia. It can't just be health authorities or regulators. It's a collective community and it has to include that patient within that conversation to help for that learning and advancement and understanding. And so I think it's something around that, the best practices, use cases, and really things that made a difference. Meeting people where they are of a good understanding of the science, not good understanding of the science, that crosses all levels. Drug development overall. The total continuity of care for my individual affected. It's not just about a drug, but it's about assistive devices or other tools that they can have a better life. And so being really thoughtful about that I think would be something that would be really amazing. That it's actually captured and taught back. [00:26:47] Lindsey Dinneen: Yeah, absolutely. That would be a fantastic masterclass. All right, and then how do you wish to be remembered after you leave this world? [00:26:56] Sara Aswegan: Well, at some point I know my husband will admit I have the best sense of humor. [00:27:01] Lindsey Dinneen: Yes. [00:27:02] Sara Aswegan: I think for me, Lindsey, I really would hope that people would say an open heart, a generous heart, and just a connector of people, personally, professionally. It takes two seconds to be kind and open and nobody has all the answers. So help people connect with others and be willing to say, "How can I help?" [00:27:20] Lindsey Dinneen: Yeah, absolutely. Yeah. And then final question, is one thing that makes you smile every time you see or think about it? [00:27:31] Sara Aswegan: I just came in from my garden and I have to say, seeing my advancement of fostering my garden and I've got things blooming now. There is hope. [00:27:40] Lindsey Dinneen: I love that. I feel that way every time I somehow succeed in keeping a plant alive. [00:27:45] Sara Aswegan: There is hope. It's really around the simple things, right? That's it. [00:27:49] Lindsey Dinneen: Yeah, absolutely. Now, for any of our listeners who are excited to get to know about you and your work a little bit more, can you just share briefly what is it that you do right now to help companies succeed and how can people get in touch with you? [00:28:02] Sara Aswegan: Thanks, Lindsey. So I am currently doing some advisory board work for a couple of consultancies as well as helping some small and mid-sized biotechs figure out their pathway and how they go to market. How do they facilitate access to unlicensed medicines? I'm passionate about the rare space, so I'm serving also on a couple of special projects on getting drugs and diagnostics into low middle income countries. And it's something I'm very passionate about and I've got a great network of people. So if I can't help, I'm always happy to say, "Not me, however, I know someone you should talk to." And to get in touch, it's not easy to spell, but it's www.saraaswegan.com. And again, if I can't help, I might know someone who can. And I think it's just, it's really good to share our knowledge and experience and really make a difference however we can. [00:28:47] Lindsey Dinneen: Yeah. Absolutely. Well, thank you, Sara. This has been absolutely incredible to learn from you, to hear about your story. So thank you for sharing and being open. I really appreciate that. And my goodness, I just wish you the most continued success as you work change lives for a better world. [00:29:03] Sara Aswegan: Thanks Lindsey, and thanks for everything you're doing. Really, hats off. Thanks a million. [00:29:07] Lindsey Dinneen: Of course, and have the best rest of your day. And thanks also to our listeners for tuning in. If you're feeling as inspired as I am right now, I'd love it if you shared this episode with a colleague or two and we'll catch you next time. [00:29:22] Ben Trombold: The Leading Difference is brought to you by Velentium. Velentium is a full-service CDMO with 100% in-house capability to design, develop, and manufacture medical devices from class two wearables to class three active implantable medical devices. Velentium specializes in active implantables, leads, programmers, and accessories across a wide range of indications, such as neuromodulation, deep brain stimulation, cardiac management, and diabetes management. Velentium's core competencies include electrical, firmware, and mechanical design, mobile apps, embedded cybersecurity, human factors and usability, automated test systems, systems engineering, and contract manufacturing. Velentium works with clients worldwide, from startups seeking funding to established Fortune 100 companies. Visit velentium.com to explore your next step in medical device development.

Kyle Chan is a Postdoctoral Research Associate and Lecturer in Sociology at Princeton University. His research focuses on industrial policy, clean technology, and infrastructure with a regional focus on China and India. He is currently working on a book on Chinese industrial policy that aims to explain how China came to dominate certain industries today that had originally been led by the US, Japan, and other industrialized nations. These industries include electric vehicles, solar, high-speed rail, and consumer electronics. The book will describe the wide range of industrial policy tools used in China and their ongoing efforts in other industries, such as semiconductors and biotechnology.Kyle Chan writes a popular newsletter called High Capacity on industrial policy, clean technology, and infrastructure, particularly in China and India.Personal website: https://www.kyleichan.com/NYT op-ed: https://www.nytimes.com/2025/05/19/opinion/china-us-trade-tariffs.htmlLu Feng interview: https://www.high-capacity.com/p/chinese-industrial-maximalismChapter Markers:(00:00) - Introduction (00:50) - Kyle's Background and Research Interests (05:51) - China vs. India: A Comparative Study of Railway Development (12:38) - The Broader Implications of Industrial Policy (37:48) - Introduction to Industrial Maximalism (38:54) - China's Manufacturing Strategy (41:33) - US-China Technological Competition (59:45) - Global Collaboration and Future Outlook Music used with permission from Blade Runner Blues Livestream improvisation by State Azure.–Steve Hsu is Professor of Theoretical Physics and of Computational Mathematics, Science, and Engineering at Michigan State University. Previously, he was Senior Vice President for Research and Innovation at MSU and Director of the Institute of Theoretical Science at the University of Oregon. Hsu is a startup founder (SuperFocus.ai, SafeWeb, Genomic Prediction, Othram) and advisor to venture capital and other investment firms. He was educated at Caltech and Berkeley, was a Harvard Junior Fellow, and has held faculty positions at Yale, the University of Oregon, and MSU. Please send any questions or suggestions to manifold1podcast@gmail.com or Steve on X @hsu_steve.

Miist is a Chinese multicultural singer with multiple Billboard hits and international awards. She's the first Chinese artist ever to land a Top 25 Billboard Pop/AC hit. She's written over 80 original songs in English, Mandarin and Spanish. And she only got started at age 34. She was abandoned at age 5 and was a terminal cancer survivor at age 28. She now serves as an ambassador for Teen Cancer America.Her newest endeavor is called the Smile Project. It's a global musical collaboration centered around the single "Could You Lend Me a Smile." The project includes multiple Grammy winners, languages, videos and performing artists.My featured song is “It Is A Miracle To Me” from the album East Side Sessions by my band, Project Grand Slam. Spotify link.------------------------------------------The Follow Your Dream Podcast:Top 1% of all podcasts with Listeners in 200 countries!Click here for All Episodes Click here for Guest List Click here for Guest Groupings Click here for Guest TestimonialsClick here to Subscribe Click here to receive our Email UpdatesClick here to Rate and Review the podcast—----------------------------------------CONNECT WITH MIIST:www.miistthesinger.com—----------------------------------------ROBERT'S NEWEST SINGLE:“SUNDAY SLIDE” is Robert's newest single. It's been called “A fun, upbeat, you-gotta-move song”. Featuring 3 World Class guest artists: Laurence Juber on guitar (Wings with Paul McCartney), Paul Hanson on bassoon (Bela Fleck), and Eamon McLoughlin on violin (Grand Ole Opry band).CLICK HERE FOR ALL LINKSCLICK HERE FOR THE OFFICIAL VIDEO—-------------------------------------------ROBERT'S NEWEST ALBUM:“WHAT'S UP!” is Robert's new compilation album. Featuring 10 of his recent singles including all the ones listed below. Instrumentals and vocals. Jazz, Rock, Pop and Fusion. “My best work so far. (Robert)”CLICK HERE FOR THE OFFICIAL VIDEOCLICK HERE FOR ALL LINKS—----------------------------------------Audio production:Jimmy RavenscroftKymera Films Connect with the Follow Your Dream Podcast:Website - www.followyourdreampodcast.comEmail Robert - robert@followyourdreampodcast.com Follow Robert's band, Project Grand Slam, and his music:Website - www.projectgrandslam.comYouTubeSpotify MusicApple MusicEmail - pgs@projectgrandslam.com 

Host Paul Gullon-Scott sits down with Tom Oldroyd, Director of Strategy and Sales at Semantics 21, to discuss S21's digital forensics platform that prioritizes investigator mental health alongside cutting-edge technology. Drawing on his 17 years in policing and experience running a digital forensic unit, Tom highlights the psychological toll on investigators exposed to disturbing content daily, arguing it's one of the most challenging yet underrecognized jobs in policing. Tom highlights Semantics 21's innovative solutions, including their Global Alliance Database with 3.1 billion hashes that can pre-label up to 70% of evidence automatically, AI-powered victim rescue tools, and their groundbreaking features to track investigator exposure levels in real-time. Tom demonstrates protective features like mandatory break reminders, privacy overlays, and decompression videos designed to help investigators manage psychological impact. #DigitalForensics #CyberInvestigation #DFIR #AI #Wellbeing 00:00 Introduction 00:30 Showcasing Semantics 21: Innovation in Digital Forensics 00:40 Protecting Investigator Wellbeing 01:53 Meet Tom Oldroyd 02:56 Challenges in Digital Forensics 06:02 The Growing Threat of Digital Crime 07:38 Global Collaboration and Technology 08:48 Introducing S21 LASERi-X 09:33 The Power of AI and Databases 12:23 Global Alliance Database: A Game Changer 16:52 Efficiency and Investigator Wellbeing 21:11 Advanced Features and Workflow 27:51 Tracking Exposure Levels with Semantics 21 28:20 Monitoring Well-Being 29:13 Handling Large Volumes of Data 30:24 Threshold System and Victim Rescue 32:27 Efficient Data Import and Grading 33:27 Global Alliance Database and Photo DNA 36:32 Wellbeing Features and Stress Management 44:00 Cross-Company Collaboration and Data Sharing 45:38 Pricing and Accessibility of Semantics 21 47:54 User Feedback and Customization 51:12 AI Location Prediction Technology 53:42 Conclusion and Contact Information Show Notes Semantics 21 - https://www.semantics21.com Semantics 21 Articles on Forensic Focus - https://www.forensicfocus.com/author/semantics21  

In this inspiring episode, Gill speaks with Noreen Remat, founder of the Life Givers Organization in Lahore, Pakistan. They explore Noreen's mission to provide education for underprivileged children in her village, her powerful personal journey, and the global collaboration that made her dream of building a school possible.Noreen opens up about the financial hardships she faced, leaving a difficult job, and persevering through repeated challenges to register her organization. With support from Aidan—who connected with her through the Global Collaboration network—Noreen has been able to continue her work and build a school that's nearly complete.Together, Gill and Noreen discuss the transformative power of education, the role of technology in connecting changemakers, and a unique model of giving where children learn to give back through love and kindness. This episode is a powerful reminder of what can happen when compassion, resilience, and global unity come together to uplift communities.Listen now to hear how faith, determination, and the kindness of strangers are changing lives through education.

Will AI displace more jobs than it creates? How can the U.S. win the AI race? How can AI benefits be evenly distributed across businesses and society?We explore these questions and more as Sriram Viswanathan sits down with Ronnie Chatterji, Chief Economist at OpenAI, for an in-depth exploration of AI's economic impact and policy implications. Ronnie brings a unique perspective, having served as an economic advisor in both the Obama and Biden administrations as a senior economist, supply chain advisor, and architect of the CHIPS Act.The conversation dives into the economic opportunities and challenges of AI adoption, from productivity gains and job market transformation to the critical need for workforce retraining and AI upskilling in schools. Ronnie also delves into America's competitive position in the global AI race, the critical need for infrastructure investment in order to continue scaling this emerging technology, and the lessons learned from implementing major industrial policy like the CHIPS Act.Links:Learn more about OpenAI's economic research and policy work - OpenAIRead OpenAI's Economic Blueprint for the US - OpenAI's Economic BlueprintExplore the CHIPS and Science Act - CHIPS.govRonnie Chatterji's academic work at Duke University - Duke Fuqua School of Business

In this episode of Idea Collider, we sit down with Susan Galbraith from AstraZeneca, a leading figure in oncology R&D. Susan shares her journey from medical training in Manchester and Cambridge to spearheading transformative cancer treatments at AstraZeneca. She discusses pivotal moments in her career, AstraZeneca's vision for eliminating cancer as a cause of death, the role of patient stories in motivating R&D efforts, and the integration of emerging technologies like AI and digital health tools.  With a focus on collaboration and continuous learning, Susan provides insights into how successful oncology drugs are developed and the importance of equitable representation in clinical trials. Stay tuned for an engaging conversation that highlights the future of personalized cancer therapies and the collaborative efforts driving innovations in oncology.Chapter Summaries;00:00 Introduction and Guest Welcome00:27 Susan Galbraith's Career Journey02:37 Defining Success in Oncology R&D05:01 Early Phase Drug Development07:09 Digital Health and Patient Experience12:37 Global Collaboration and Innovation15:05 AI and Future of Oncology28:08 Diversity and Inclusion in Clinical Trials33:46 Mentorship and Career Advice37:45 Challenges and Future Outlook in Oncology42:06 Closing Remarks and Call to Action Don't forget to Like, Share, Subscribe, Rate, and Review! Keep up with Susan Gabraith;LinkedIn: https://www.linkedin.com/in/susan-galbraith-584a195/?originalSubdomain=uk Follow Mike Rea On;Website: https://www.ideapharma.com/X: https://x.com/ideapharmaLinkedIn: https://www.linkedin.com/in/bigidea/ Listen to more fantastic podcast episodes: https://podcast.ideapharma.com/

Superpowers for Good should not be considered investment advice. Seek counsel before making investment decisions. When you purchase an item, launch a campaign or create an investment account after clicking a link here, we may earn a fee. Engage to support our work.Watch the show on television by downloading the e360tv channel app to your Roku, AppleTV or AmazonFireTV. You can also see it on YouTube.Devin: What is your superpower?Cameron: Ability to foster collaboration and build meaningful connections.Peter: Courage to speak truth, even when facing potential backlash.A major obstacle to global prosperity is the chronic underfunding of small and medium-sized enterprises (SMEs), especially in emerging markets. In this episode of Superpowers for Good, Cameron Neil, CEO of LendForGood, and Peter Rostovsky, CEO of Raiseway, discussed their new collaboration that aims to close that gap. Together, they're making it easier for impact-driven businesses to raise capital and for everyday people to lend across borders.LendForGood is already empowering impact enterprises in places like Asia, Africa, Latin America, and beyond to access much-needed debt financing from a global pool of lenders. Now, with Raiseway's support, these entrepreneurs will have access to tools that make running a crowdfunding campaign simpler, more efficient and more likely to succeed.Peter explained, "There are so many elements to a crowdfunding campaign...this is super challenging even for large organizations...we want to be that platform that supports the campaign throughout the process."The two companies align not just in function, but in values. Cameron emphasized that "the gap for small business capital access is significant...it's a real growing problem" that requires global infrastructure and collaboration to solve. The World Bank and UN have estimated that SMEs in emerging markets face an annual $5 trillion funding shortfall. The traditional financial system simply isn't built to serve them effectively. As banks consolidate, smaller loans become less profitable and more scarce.Raiseway and LendForGood aim to fill that void. Their shared belief in the potential of debt crowdfunding—versus equity financing, which isn't ideal for most small businesses—fuels their work. As Peter noted, "Your community is never going to foreclose you."Though not currently raising capital through a regulated investment crowdfunding campaign, both platforms are building the infrastructure and momentum for an ecosystem where everyday investors can meaningfully support small businesses doing good in the world.This collaboration underscores the power of mission-aligned tech partnerships to tackle some of the world's most stubborn problems. By streamlining access to impact capital, they're helping to rewrite the rules of small business finance—on a global scale.tl;dr:LendForGood and Raiseway collaborate to simplify cross-border impact crowdfunding and support small businesses globally.Cameron explains how LendForGood connects global lenders with impact enterprises needing debt financing.Peter shares Raiseway's role in streamlining campaigns and making crowdfunding more accessible and effective.Cameron and Peter discuss the massive global SME funding gap and why crowd lending is a vital solution.They reveal their superpowers—collaboration and courage—and offer tips on using them to drive meaningful impact.How to Develop Collaboration and Connectivity As a SuperpowerCameron Neil's superpower lies in his ability to foster collaboration and build meaningful connections. Reflecting on his approach, he shared, “I have found an ability to… build collaborative initiatives, to build posses… or a network to form.” Cameron's knack for bringing people together with shared goals and inspiring them to work collectively has been a cornerstone of his success. He credits this skill with driving impactful projects like LendForGood's partnership with Raiseway.Illustrative Anecdote:Cameron's collaboration with Peter Rostovsky is a testament to his superpower. By recognizing the synergy between LendForGood and Raiseway, Cameron initiated a partnership that equips impact enterprises with tools to succeed in crowdfunding. Reflecting on this collaboration, he explained, “Peter and I connected and we took it somewhere… bringing our organizations and others on this journey.”Tips for Developing the Superpower:Visualize Outcomes: Identify a future state or goal that requires collective effort to achieve.Seek Alignment: Find individuals or organizations that share your objectives and values.Inspire Participation: Use your vision to motivate others to join and contribute meaningfully.Build Trust: Focus on integrity and mutual respect to strengthen collaborative relationships.Embrace Diversity: Collaborate with people who bring complementary skills and perspectives.By following Cameron's example and advice, you can make collaboration and connectivity a skill. With practice and effort, you could make it a superpower that enables you to do more good in the world.How to Develop Courage to Speak Truth As a SuperpowerPeter Rostovsky's superpower is his courage to speak truth, even when facing potential backlash. Reflecting on a life-changing moment, Peter shared, “Something drastic really changed… I started being far more open about my views.” This courage to express his convictions, even at the cost of venture investor interest, has strengthened his connection with supporters and colleagues. His openness has inspired others, creating a space for dialogue and solidarity.Illustrative Anecdote:Peter's courage was tested following October 7th, when he began publicly sharing his views on Israel's policy in Gaza. Despite knowing that his candidness would alienate venture investors, Peter chose integrity over business interests. This bold stance not only demonstrated his values but also attracted a supportive community that shares his vision for Raiseway.Tips for Developing the Superpower:Find Supportive Allies: Surround yourself with people who encourage and respect your honesty.Prioritize Integrity: Focus on values over short-term gains to build lasting trust.Practice Courage: Start by sharing your beliefs in safe spaces before expanding to larger platforms.Embrace Vulnerability: Accept the risks of being open as a necessary part of authentic communication.By following Peter's example and advice, you can make courage to speak truth a skill. With practice and effort, you could make it a superpower that enables you to do more good in the world.Remember, however, that research into success suggests that building on your own superpowers is more important than creating new ones or overcoming weaknesses. You do you!Guest ProfileCameron Neil (he/him):Co-Founder and CEO, LendForGoodAbout LendForGood: LendForGood is a global impact loan syndication platform mobilising millions in impact finance for the UN Sustainable Development Goals. Entrepreneur support organisations, accelerators, incubators, venture studios and early stage investors use LendForGood to run campaigns and raise impact debt from both our individual and organisational lender community and the supporters of their portfolio enterprises who are borrowing. Investors use LendForGood to efficiently discover and deploy capital to courageous impact enterprises helping to deliver the SDGs around the world. Website: lendforgood.ioBiographical Information: Cameron Neil is the co-founder, director and CEO of LendForGood, an impact loan syndication platform that is mobilising millions of dollars to help achieve the Sustainable Development Goals. Has has three decades of experience in the impact sector, working across and between finance, business, technology, international development, corporate advisory and startups. Cameron played a pioneering role in the Fairtrade movement in the region, as well as the early days of B-Corp and Shared Value. His work now focuses on capital entrepreneurship and innovative finance to meet the challenges of the 21st century. As demonstrated through LendForGood, Cameron believes strongly in the power of people to come together in solidarity and through collaboration to create the communities and world that they want - 'all of us' is the largest untapped impact investment fund in the world!Linkedin: linkedin.com/company/lendforgoodGuest ProfilePeter Rostovsky (he/him):Co-Founder and CEO, RaisewayAbout Raiseway: Raiseway is developing an affordable SaaS platform to equip businesses with AI-enabled tools to execute effective crowdfunding campaigns on platforms like LendForGood.Website: raiseway.appCompany Facebook Page: facebook.com/raisewayappBiographical Information: Born and raised in St. Petersburg, Russia, Peter moved to New York at the age of 16. Peter studied political science and economics at CUNY Hunter College. Before joining the crowdfunding industry, he worked as a capital markets intelligence salesman. Personal Facebook Profile: facebook.com/peter.rostovsky.7Linkedin: linkedin.com/in/peter-rostovskyInstagram Handle: @pool_breadSupport Our SponsorsOur generous sponsors make our work possible, serving impact investors, social entrepreneurs, community builders and diverse founders. Today's advertisers include FundingHope, KribSavUp, SuperCrowd25, and Crowdfunding Made Simple. Learn more about advertising with us here.Max-Impact MembersThe following Max-Impact Members provide valuable financial support:Carol Fineagan, Independent Consultant | Lory Moore, Lory Moore Law | Marcia Brinton, High Desert Gear | Paul Lovejoy, Stakeholder Enterprise | Pearl Wright, Global Changemaker | Ralf Mandt, Next Pitch | Scott Thorpe, Philanthropist | Matthew Mead, Hempitecture | Michael Pratt, Qnetic | Sharon Samjitsingh, Health Care Originals | Add Your Name HereUpcoming SuperCrowd Event CalendarIf a location is not noted, the events below are virtual.Impact Cherub Club Meeting hosted by The Super Crowd, Inc., a public benefit corporation, on May 20, 2025, at 1:00 PM Eastern. Each month, the Club meets to review new offerings for investment consideration and to conduct due diligence on previously screened deals. To join the Impact Cherub Club, become an Impact Member of the SuperCrowd.SuperCrowdHour, May 21, 2025, at 1:00 PM Eastern. Devin Thorpe, Champion of Social Good and CEO of The Super Crowd, Inc., will lead a session on "The Secret to Higher Investment Returns via Impact Crowdfunding." He'll share powerful strategies and real-world examples that show how aligning your investments with your values can lead to strong financial and social returns. If you're an investor looking to maximize impact or curious about the growing world of impact crowdfunding, this is a session you won't want to miss! Don't miss it!SuperCrowd25, August 21st and 22nd: This two-day virtual event is an annual tradition but with big upgrades for 2025! We'll be streaming live across the web and on TV via e360tv. Soon, we'll open a process for nominating speakers. Check back!Community Event CalendarSuccessful Funding with Karl Dakin, Tuesdays at 10:00 AM ET - Click on Events.African Diaspora Investment Symposium 2025 (ADIS25), Wednesday–Friday, May 28–30, 2025, at George Washington University, Washington, D.C., USA.Regulated Investment Crowdfunding Summit 2025, Crowdfunding Professional Association, Washington DC, October 21-22, 2025.Call for community action:Please show your support for a tax credit for investments made via Regulation Crowdfunding, benefiting both the investors and the small businesses that receive the investments. Learn more here.If you would like to submit an event for us to share with the 9,000+ changemakers, investors and entrepreneurs who are members of the SuperCrowd, click here.We use AI to help us write compelling recaps of each episode.Manage the volume of emails you receive from us by clicking here. Get full access to Superpowers for Good at www.superpowers4good.com/subscribe

Tune into our new episode of #SCIP I_STREAM and join Lee Kantor, Founder, marketer, radio and podcast host at Business RadioX® in conversation with Paul Santilli, CEO at SCIP. Discover how SCIP is advancing data-driven growth, evolving beyond Competitive Intelligence (CI) to embrace economic and social Intelligence. From navigating post-COVID data challenges to the importance of critical thinking, education, and global collaboration—this podcast is a must-listen for today's Intelligence leaders.

How do top policymakers balance fostering technological advancement with necessary oversight? Join Michael Krigsman as he speaks with Lord Chris Holmes and Lord Tim Clement-Jones, members of the UK House of Lords, for a deep dive into the critical intersection of technology policy, innovation, and public trust.In this conversation, explore:-- The drive for "right-sized" AI regulation that supports innovators, businesses, and citizens.-- Strategies for effective AI governance principles: transparency, accountability, and interoperability.-- The importance of international collaboration and standards in a global tech ecosystem.-- Protecting intellectual property and creators' rights in the age of AI training data.-- Managing the risks associated with automated decision-making in both public and private sectors.-- The push for legal clarity around digital assets, tokenization, and open finance initiatives.-- Building and maintaining public trust as new technologies become more integrated into society.Gain valuable perspectives from legislative insiders on the challenges and opportunities presented by AI, digital assets, and data governance. Understand the thinking behind policy decisions shaping the future for business and technology leaders worldwide.Subscribe to CXOTalk for more conversations with the world's top innovators: https://www.cxotalk.com/subscribeRead the full transcript and analysis: https://www.cxotalk.com/episode/ai-digital-assets-and-public-trust-inside-the-house-of-lords00:00 Balancing Innovation and Regulation in AI02:48 Principles and Frameworks for AI Regulation09:30 Global Collaboration and Challenges in AI and Trade15:25 The Role of Guardrails and Regulation in AI17:43 Challenges in Protecting Intellectual Property in AI22:32 AI Regulation and International Collaboration29:11 The UK's Approach to AI Regulation32:00 Proportionality and Sovereign AI36:28 Digital Sovereignty and Creative Industries39:09 The Future of Digital Assets and Legislation40:53 Open Banking, Open Source Models, and Agile Regulation45:43 Ethics and Professional Standards in AI47:22 Exploring AI and Ethical Standards49:00 AI in the Workplace and Global Accessibility51:40 Regulation, Public Trust, and Ethical AI#cxotalk #AIRegulation #AIInnovation #DigitalAssets #PolicyMaking #UKParliament #TechPolicy #Governance #PublicTrust #LordChrisHolmes #LordTimClementJones

In today's episode of our CVC series, Andreas Munk Holm and our CVC in-house expert, Jeppe Høier, talk with Ida Christine Brun, Venture Investments and Partnership Director at Maersk Growth. With over 13 years at Maersk under her belt, Ida brings experience from commercial business development and supply chain management to her current role in corporate venturing. She explains how Maersk Growth invests in early-stage startups focused on decarbonizing and digitizing supply chains, using a well-rounded approach that blends equity investments with strategic partnerships.During the conversation, Ida shares how her team leverages Maersk's deep logistics expertise to test and validate innovative solutions in real-world settings. She discusses the value of engaging with both internal teams and external VC partners to drive impactful change, emphasizing the importance of addressing current business challenges and paving the way for future growth. By integrating strategic insights with practical pilot projects, Maersk Growth is working to bridge the gap between groundbreaking technology and sustainable, long-term industry transformation.Go to eu.vc for our core learnings and the full video interview

SWAB  is currently recruiting volunteers to assist in Myanmar following the devastating earthquake having trained social workers for over a decade to be first responders.

The MTU Innovation Challenge 2025 has once again demonstrated the transformative power of student-led innovation, as interdisciplinary teams from across the globe came together to tackle real-world challenges posed by local, regional, and international organisations. Over the course of the last eight weeks, 11 teams of students from across Munster Technological University's six campuses in Cork and Kerry collaborated with their peers from Ud'A University in Italy, Murang'a University of Technology in Kenya, the University of Skövde in Sweden, and the University of Crete in Greece. Together, they engaged in solving a diverse range of innovation challenges supported by expert mentoring and training in design thinking and stakeholder engagement. Each team worked closely with real-world organisations to develop creative, practical solutions to problems currently affecting those organisations. The teams were supported by a group of volunteer mentors from across MTU without whom the challenge would not be possible. This year's participating organisations come from a wide variety of sectors, including healthcare, agriculture, assistive technology, AI, and nonprofit services. Challenges ranged from implementing AI solutions for business process automation to designing accessible healthcare devices to improving sustainable farming tools and community engagement platforms. Students tackled projects including the development of an AI-powered supply chain tool for tech firm Aspen Grove, the design of a paediatric syringe driver lockbox for Cork University Hospital, and a reimagined neck support brace for Motor Neurone patients at Marymount Hospice. In the nonprofit and community space, students designed an interactive app for Irish Guide Dogs for the Blind to engage users in a service dog's journey, contributed to a digital portal for clients at the Crann Centre, and explored improvements to solar-powered irrigation systems and data platforms with Kenyan start-up SowPrecise. Carole O'Leary, who spearheads this initiative at MTU, said: "These projects are not hypothetical scenarios, these are real issues facing organisations right now. What's remarkable is how our students rise to meet these complex challenges with such creativity, empathy, and professionalism. The benefits are two-fold: the organisations gain fresh perspectives and potential solutions, while students gain hands-on experience and the confidence to innovate in the real world." To mark their achievements, two standout teams were each awarded a €1,000 prize for their innovative and impactful solutions: Team Marymount 1 and Team SowPrecise 1. All students participating in the challenge received a Digital Badge in recognition of their engagement, collaboration, and contribution. From a stakeholder perspective, the benefits were evident. "The MTU Innovation Challenge has been such a highlight for me this year, and it is so exciting and rewarding to work with the students at MTU," said Orlaith Leo, Leo Senior Physiotherapist at Marymount Hospice. "To put my clinical head together with their creative minds has been so valuable, and they've come up with some brilliant ideas I could never have imagined." Gemma Leo, Business Support and Project Manager at the Crann Centre, shared similar praise: "The apps that we saw were absolutely beautiful - so a massive congratulations to the students. I can totally see that if we can get them built, our clients would use them." The 2025 challenge welcomed the most academically diverse group to date, with participation from both undergraduate and postgraduate students across a wide range of disciplines. These included programmes in Mechanical and Biomedical Engineering, Software Development, Computing, Creative Digital Media, Animation and Visual Effects, Business Information Systems, International Business, Marketing, Economics, Data Science and Analytics, Artificial Intelligence, User Experience and Service Design, Electrical and Electronics...

keywordscybersecurity, 5G, 6G, AI, quantum computing, global collaboration, career advice, creativity, technology, Dr. Anmol AgarwalsummaryIn this episode of No Password Required, host Jack Clabby and cybersecurity expert Dr. Anmol Agarwal discuss the evolving landscape of cybersecurity, focusing on the challenges and innovations surrounding 5G and 6G networks, the integration of AI and quantum computing, and the importance of global collaboration in addressing cybersecurity threats. Dr. Agarwal shares her insights on the significance of creativity in the field, offers advice for those entering the cybersecurity space, and engages in a fun lifestyle polygraph segment that highlights her personal interests and professional aspirations.takeawaysStart posting about what you're learning immediately to gain exposure.The transition from 5G to 6G involves long-term security thinking.AI and quantum computing are complementary technologies in cybersecurity.Global collaboration is essential for effective cybersecurity solutions.Creativity is crucial in addressing emerging cybersecurity challenges.Focus on personal interests rather than peer pressure in career choices.Healthcare is a sector particularly vulnerable to AI-driven attacks.Continuous learning and sharing knowledge is vital for career growth.Security standardization is a key aspect of developing new technologies.Engagement and interaction are important in educational and professional settings.titlesNavigating the Future of CybersecurityThe 6G Security LandscapeAI and Quantum: The New FrontierCollaborative Cybersecurity: A Global PerspectiveSound Bites"Start posting about what you're learning immediately.""We're going to be thinking in a serious way.""My role specifically on this team is security standardization.""I want to work on AI security.""Security is a team effort.""AI can make mistakes as well.""Focus on what you like instead of worrying about others.""Creativity is probably the most important thing.""I would add a journalist to my cybersecurity dream team."Chapters00:00 Introduction to Cybersecurity Insights02:30 Exploring 5G and 6G Security Challenges11:10 The Intersection of AI, Quantum Computing, and Cybersecurity18:00 Global Collaboration in Cybersecurity24:57 Advice for Aspiring Cybersecurity Professionals26:48 The Role of Creativity in Cybersecurity31:27 Lifestyle Polygraph: Fun and Insightful Questions

In Thailand at Funding the Commons I spoke to Jake Hartnell, co-founder of Layer, a modular tech stack to build decentralized protocols using Eigen Layer's shared security. Jake is also a contributor to Juno and DAO DAO in the Cosmos ecosystem.During the discussion we simplify how Eigen Layer works, what new affordances it brings, and what it means for collaborating across state lines. What is something that is normally being associated with hyper-financialization of computation can also be used to build the international commons.If you liked the podcast be sure to give it a review on your preferred podcast platform. If you find content like this important consider donating to my Patreon starting at just $3 per month. It takes quite a lot of my time and resources so any amount helps. Follow me on Twitter (@TBSocialist) or Mastodon (@theblockchainsocialist@social.coop) and join the r/CryptoLeftists subreddit and Discord to join the discussion.Send me your questions or comments about the show and I'll read them out sometime. Support the showICYMI I've written a book about, no surprise, blockchains through a left political framework! The title is Blockchain Radicals: How Capitalism Ruined Crypto and How to Fix It and is being published through Repeater Books, the publishing house started by Mark Fisher who's work influenced me a lot in my thinking. The book is officially published and you use this linktree to find where you can purchase the book based on your region / country.

Dr. Kerl is pleased to welcome Dr. Sibele Konno to the VCA Voice Podcast. In their conversation, she shares her journey into veterinary medicine, discussing her early inspirations, the landscape of veterinary education in Brazil, and the challenges faced by new graduates. Dr. Konno reflects on her career evolution, her leadership role at Petcare Brazil, and the importance of quality care in veterinary practices. The discussion highlights the significance of hands-on training, the impact of leadership in veterinary care, and the growth of Petcare Brazil under her guidance. In this conversation, Marie and Sibele discuss the innovative pet care services offered in Brazil, including specialized medical treatments and the importance of training new veterinarians through internship programs. They explore the challenges faced by veterinary technicians in Brazil and the potential for future certification. Their discussion also highlights the cultural differences in veterinary practices between Brazil and the U.S., as well as the evolving relationship between pet owners and veterinarians, emphasizing the need for effective communication and understanding of pet parents' expectations.Visit our website: vcavoice.comAll episodes produced by dādy creative

The UN chief has issued a stark warning for humanity in his speech at the World Economic Forum Annual Meeting in Davos(1:08). China plans to promote the modernization of agriculture and rural areas to a new stage by 2027(9:24). The South Korean president has attended the fourth hearing of his impeachment trial(19:20).

It's the Ranch It Up Radio Show Herd It Here Weekly Report!  A 3-minute look at cattle markets, reports, news info, or anything that has to do with those of us who live at the end of dirt roads.  Join Jeff 'Tigger' Erhardt, the Boss Lady Rebecca Wanner aka 'BEC' by subscribing on your favorite podcasting app or on the Ranch It Up Radio Show YouTube Channel. EPISODE 62 DETAILS Global Concern Over Avian Influenza In Mammals WOAH Raises Concern Over High Pathogenicity Avian Influenza (HPAI) in Mammals, Including U.S. Dairy Cattle The World Organisation for Animal Health (WOAH) has issued an urgent warning regarding the increasing spread of high pathogenicity avian influenza (HPAI) to mammals, including dairy cattle in the United States. As of November 2024, the virus has been detected in over 30 mammalian species, with cases projected to rise in the Northern Hemisphere through February. HPAI's Impact on Mammals and Dairy Cattle Recent studies reveal that raw milk from HPAI-infected cows poses significant risks, as the virus can transmit to other animals, including poultry and cats. This finding underscores the critical need for immediate and stringent measures to prevent the spread of this zoonotic disease. Public Health Risk: Low but Requires Vigilance WOAH emphasizes that, while the public health risk from HPAI remains low, the situation demands proactive efforts from nations worldwide. The organization recommends several key actions to mitigate risks: Enhance Surveillance: Monitor birds and cattle closely for HPAI symptoms. Accurate Diagnoses: Ensure HPAI is considered when livestock exhibit compatible symptoms. Timely Reporting: Promptly notify WOAH of any unusual cases in mammals. Strengthen Biosecurity: Implement strict biosecurity measures, including restrictions on raw milk from infected animals. Preventing Trade Disruptions and Promoting Research WOAH has cautioned against imposing unnecessary trade restrictions in response to HPAI, urging adherence to its established international standards. Collaborative research is ongoing to deepen the understanding of the virus's pathogenesis and transmission routes. Global Collaboration to Combat HPAI WOAH remains committed to supporting global efforts against HPAI through technical updates, partnerships, and international cooperation. These measures aim to mitigate the risks posed by this evolving virus and safeguard both animal and human health. Stay informed about the latest developments in HPAI prevention and containment by following updates from WOAH and related authorities.   SPONSORS Trans Ova Genetics https://transova.com/ @TransOvaGenetics American Gelbvieh Association https://gelbvieh.org/ @AmericanGelbvieh Allied Genetic Resources https://alliedgeneticresources.com/ @AlliedGeneticResources Clear Springs Cattle Company https://www.bredforbalance.com/female-sale Axiota Animal Health https://axiota.com/ @MultiminUSA Jorgensen Land & Cattle https://jorgensenfarms.com/ @JorLandCat Ranch Channel https://ranchchannel.com/ @RanchChannel   Questions & Concerns From The Field? Call or Text your questions, or comments to 707-RANCH20 or 707-726-2420 Or email RanchItUpShow@gmail.com FOLLOW Facebook/Instagram: @RanchItUpShow SUBSCRIBE to the Ranch It Up YouTube Channel: @ranchitup Website: RanchItUpShow.com https://ranchitupshow.com/ The Ranch It Up Podcast is available on ALL podcasting apps. https://ranchitup.podbean.com/   Rural America is center-stage on this outfit. AND how is that? Because of Tigger & BEC... Live This Western Lifestyle. Tigger & BEC represent the Working Ranch world by providing the cowboys, cowgirls, beef cattle producers & successful farmers the knowledge and education needed to bring high-quality beef & meat to your table for dinner. Learn more about Jeff 'Tigger' Erhardt & Rebecca Wanner aka BEC here: TiggerandBEC.com https://tiggerandbec.com/ #RanchItUp #StayRanchy #TiggerApproved #tiggerandbec #rodeo #ranching #farming REFERENCES https://www.meatingplace.com/Industry/News/Details/117372

Tammy Haddad interviews Courtney O'Donnell, U.S. Ambassador to the United Nations Educational, Scientific and Cultural Organization (UNESCO), and Sean Patrick Maloney, U.S. Ambassador to the Organization for Economic Co-Operation and Development (OECD), for a deep dive into AI's transformative impact from Paris. O'Donnell shares UNESCO's initiatives in using AI to advance global education, protect cultural heritage, and preserve indigenous languages, emphasizing a human-centered approach. Maloney outlines the OECD's pivotal role in fostering multilateral AI cooperation, promoting inclusivity, and embedding ethical principles into AI frameworks. They address critical topics, including AI's energy demands, healthcare advancements like AI-powered tuberculosis diagnostics in India, and the urgency of global collaboration to ensure equitable access to AI's benefits.

In this episode, Russ Branzell, CHIME President & CEO, talks with Dr. Sangita Reddy, Joint Managing Director at Apollo Hospitals, about digital health's role in global collaboration.

The COVID-19 pandemic was a wake-up call for governments and their global stakeholders to reform the management processes of infectious disease outbreaks. Dr Stella Chungong and Dr Landry Ndriko Mayigane of the Health Security Preparedness Department of the World Health Organization's Health Emergencies Programme are encouraging countries to implement early action reviews (EARs) for disease outbreaks to assess their vigilance and planning, the responsiveness of their health systems, and to better prepare for outbreaks.Read more in Research OutreachRead the original research: doi.org/10.1016/S2214-109X(23)00167-5

Tune in to the latest episode of The Better Samaritan Podcast as Neil Hart shares his inspiring story. Hear how he pivoted from a life in farming to becoming the leader of the Mergon Foundation. We dive into his faith-driven path, showcasing the power of long-term relationships and innovative philanthropy. We also explore the global impact of the 54 Collective, a collaborative platform developing organizational health worldwide. With a focus on creativity, adaptability, and divine guidance, Neil's inspiring story offers invaluable insights for anyone interested in mission-driven work and impactful partnerships. Listen in to learn more :  ​​(01:47) Partnering With Ministries Across the Region  (11:21) Journey of Faith and Creativity  (13:53) The Power of Humility and Partnership  (17:45) Global Collaboration for Free Educational Courses  (23:06) Ministry Learning Journeys Organization and Structure  Bio: Neil Hart is the head of the Mergon Foundation. Before joining in 2018, he founded and led a creative brand marketing agency, led global missions and church planting organizations, and was involved in several church planting movements. Neil holds a BA in graphic design from Nelson Mandela University. Resources: Mergon Foundation 54 Collective  Spiritual First Aid Download your free copy of our Called to Serve: Navigating Your Christian Vocation in Humanitarian, Disaster, and Development Work e-book, which includes articles full of practical advice, insight, and encouragement. Each of the three sections concludes with thought-provoking questions and a prayer. We hope this e-book informs and also guides you toward reflection, prayer, and next steps.  ------------ This episode was produced by WildfireCreative  Theme Song: “Turning Over Tables” by The Brilliance Subscribe: Apple Podcasts | Google Podcasts | Spotify | TuneIn | Stitcher | RSS Follow us on Twitter:  @drjamieaten |  @kentannan Follow on Instagram: @wildfirecreativeco @wheaton_hdi (Note to the listener: In this podcast, sometimes we'll host Evangelicals, and sometimes we won't. Learning how to “do good, better” involves listening to many perspectives with different insights and understanding. Sometimes, it will make us uncomfortable; sometimes, we'll agree, and sometimes, we won't. We think that's good. We want to listen for correction–especially in our blind spots.) The Better Samaritan podcast is produced by the Humanitarian Disaster Institute at Wheaton College, which offers an M.A. in Humanitarian & Disaster Leadership and a Trauma Certificate. To learn more and apply, visit our website. Jamie Aten, Ph.D., and Kent Annan, M.Div., co-direct the Humanitarian Disaster Institute at Wheaton College and are the Co-Founders of Spiritual First Aid. Learn more about your ad choices. Visit podcastchoices.com/adchoices

Anne Bouverot, France's Special Envoy for AI, joins host Tammy Haddad to discuss the highly anticipated 2025 AI Action Summit, which aims to unite global leaders and innovators in shaping the future of AI. Recorded at STATION F in Paris, the conversation dives into pressing issues such as AI's impact on climate change, its transformative effects on the workforce, and the need for inclusivity and equity in its development. Bouverot emphasizes the summit's mission to balance AI's risks and opportunities while fostering trust through scientific consensus.

Guest: Ambassador Brendan Dowling, Ambassador for Cyber Affairs and Critical Technology, DFATOn LinkedIn | https://www.linkedin.com/in/brendan-dowling-7812b4261/AT AU Cyber Con | https://canberra2024.cyberconference.com.au/speakers/brendan-dowlingHosts: Sean Martin, Co-Founder at ITSPmagazine [@ITSPmagazine] and Host of Redefining CyberSecurity Podcast [@RedefiningCyber]On ITSPmagazine | https://www.itspmagazine.com/sean-martinMarco Ciappelli, Co-Founder at ITSPmagazine [@ITSPmagazine] and Host of Redefining Society Podcast & Audio Signals PodcastOn ITSPmagazine | https://www.itspmagazine.com/itspmagazine-podcast-radio-hosts/marco-ciappelli____________________________Episode NotesThis conversation with Brendan Dowling gave us a glimpse into the strategies, challenges, and collaborations shaping Australia's digital future—and reminded us all that the cyber frontier is not just a technical battlefield but a deeply human one.The Role of a Cyber AmbassadorDowling began by discussing the unique responsibilities of a Cyber Ambassador, a role that integrates cybersecurity into foreign policy at the highest levels. He emphasized how this position, once viewed as an innovative experiment, has become a strategic necessity for national security. As cyber threats grow increasingly complex and borderless, cyber diplomacy has emerged as a critical tool for fostering stability and trust on the global stage.Strengthening Global CollaborationDuring the discussion, Dowling highlighted the collaborative nature of Australia's cybersecurity efforts. He explained how cooperation within government agencies and partnerships with international allies are key to staying ahead of emerging threats. These relationships enable critical information-sharing, strategic alignment, and unified responses to incidents, underscoring the interconnectedness of today's digital ecosystem.Navigating AI and Ethical ChallengesThe conversation turned to artificial intelligence and its growing role in society. Dowling addressed the ethical considerations of AI development and deployment, stressing the importance of balancing innovation with responsibility. He described Australia's approach to advocating for ethical design and policy frameworks that protect privacy and human rights while maximizing AI's benefits.Building Resilience in Critical InfrastructureCritical infrastructure was another focal point of the discussion. Dowling acknowledged the increasing complexity of protecting vital systems, from industrial control processes to supply chains. He emphasized resilience—not only in preventing attacks but in responding swiftly and effectively when incidents occur. This approach ensures that essential services, such as energy and manufacturing, can continue to operate even under pressure.Cultural Contexts in CybersecurityDowling also reflected on the role of cultural differences in shaping cybersecurity strategies. He shared experiences from his international work, where addressing issues like online safety and disinformation often requires sensitivity to local norms and values. Tailoring cybersecurity approaches to diverse cultural contexts, he noted, is vital for fostering trust and collaboration across regions.Conclusion:As the conversation concluded, Dowling reaffirmed the need for continued cooperation, innovation, and cultural understanding in tackling global cyber challenges. Sean Martin and Marco Ciappelli expressed their gratitude, leaving listeners with a clear message: cybersecurity is not just a technical issue—it's a global, ethical, and deeply human challenge that requires collective effort.____________________________This Episode's SponsorsThreatlocker: https://itspm.ag/threatlocker-r974____________________________ResourcesAustralia's global opportunity and responsibility: shaping a more secure region and a safer digital world (Session): https://canberra2024.cyberconference.com.au/sessions/australias-global-opportunity-and-responsibility-shaping-a-more-secure-region-and-a-safer-digital-worldLearn more and catch more stories from Australian Cyber Conference 2024 coverage: https://www.itspmagazine.com/australian-cyber-conference-melbourne-2024-cybersecurity-event-coverage-in-australiaBe sure to share and subscribe!____________________________Catch all of our event coverage: https://www.itspmagazine.com/technology-cybersecurity-society-humanity-conference-and-event-coverageTo see and hear more Redefining CyberSecurity content on ITSPmagazine, visit: https://www.itspmagazine.com/redefining-cybersecurity-podcastTo see and hear more Redefining Society stories on ITSPmagazine, visit:https://www.itspmagazine.com/redefining-society-podcastWant to tell your Brand Story Briefing as part of our event coverage?Learn More

Hi Friends, Firstly a huge THANK YOU to our beautiful global collaborators for gifting us their presence for this podcast, we greatly appreciate and value you all

Yes, there is a market north of the border! The Toronto area is huge and deserves its own lighting show. Gaurav saw the opportunity and jumped on it all the way from India. With his company, MEX Exhibitions, he plans to “provide a platform for the lighting community to engage in meaningful dialogue and explore the future of smart lighting, LED technology, and design.” And he's getting help from The Lighting Agora's Tom Butters who is acting as the Knowledge Partner for the educational program. Spoiler alert - we'll be there live streaming from the Get A Grip On Lighting booth! Bonus as a GAGOL listener: use the code NAILD40 to receive a discount on your registration fees. Gaurav Juneja, Director of MEX Exhibitions Pvt. Ltd. and MEX International Inc., is a pioneering leader in the B2B exhibition industry specifically for lighting industry, apart from many other Industry Verticals. He has played a transformative role in the industry, most notably through his leadership in launching major trade shows that have become flagship events in each sector. Gaurav was instrumental in the launch of LED Expo India in 2009, a ground breaking platform that introduced the Indian market to advanced LED technologies and solutions, helping accelerate the adoption of energy-efficient lighting across the country. Following its success, Gaurav spearheaded the expansion of the brand into Southeast Asia by establishing LED Expo Thailand in 2013, making it one of the largest and most influential lighting shows in the ASEAN region. Tom Butters, LC, is the creative mind and developer behind some of the most well received educational tools and events of the global lighting industry. Since 1986, Tom has worked in or served the entire array of the lighting industry. He uses this diverse background and empathy to understand the needs of the individual or organization to deliver high quality lighting education to suit the precise needs of the user. Tom is a proud board member of the Nuckolls' Fund for Lighting Education and an Emeritus Member of the IES. As the Senior Manager then Director of Canlyte/Philips Lighting Concept Centre in Toronto, Ontario, Canada from 2000 to 2016, Tom developed and delivered top level lighting education to thousands of attendees in all segments of the lighting industry. Tom was the co-developer, along with F.X. Morin, of the globally successful free lighting app “IES Ready Reference”. He is the creator of “Light for Life – a Global Collaboration 2020” which involved 17 webinars from 15 lighting organizations from around the world during the COVID-19 pandemic. Tom was the director of the IES' free 4-hour live webinar “Germicidal Disinfection in the Days of COVID-19” which had over 3600 live attendees from 56 countries and has been viewed by thousands more as a free offering on the IES website. 

In this episode of Why Distance Learning, hosts Seth Fleischauer, Allyson Mitchell, and Tami Moehring welcome Maddie Roach, the Distance Learning Specialist at the National World War II Museum. Maddie shares her experiences building engaging virtual programs that connect learners to history in unique ways, discusses how the museum adapted post-Katrina, and explores how distance learning makes education accessible across the globe.Key Topics Discussed:Maddie's journey from museum volunteer to distance learning specialist.The development of digital exhibits and synchronous virtual field trips.Operation Foot Locker, a program that ships World War II artifacts to classrooms.The museum's mission to preserve history and teach lessons of tolerance.Golden moments when students connect personally with history, including stories from underrepresented groups.The importance of balancing synchronous and asynchronous learning experiences.In-depth insights for educators:Maddie explains how distance learning bridges physical gaps and brings the museum to students worldwide. She discusses how their programs meet the needs of diverse audiences, from K-12 classrooms to lifelong learners, and shares strategies to create meaningful connections through primary sources and oral histories.Call to Action:Tune in to this episode to discover how Maddie and her team use technology to make history come alive. Learn how virtual programs like Operation Foot Locker and interactive webinars are transforming history education. Check the show notes for links to the National World War II Museum's virtual offerings and explore how to bring these experiences into your classroom.About today's guest:Maddie Roach is the Distance Learning Specialist at the National World War II Museum. With a background in history and public history from the University of New Orleans, Maddie blends her love of technology and education to develop engaging, meaningful virtual programs for learners around the world.See the museum's promo video, featuring Maddie and mentioned in the episode: https://www.youtube.com/watch?v=5QBMSd7fLxsHost Links:Discover more virtual learning opportunities at CILC.org with Tami Moehring and Allyson Mitchell.Seth Fleischauer's Banyan Global Learning has performed over 40k live virtual teaching periods while improving students' language, digital, and cultural competencies.

On this episode of DGTL Voices, Ed sits down with Michael Nusbaum, an independent healthcare consultant and a true pioneer in the digital health space. Michael's journey is anything but conventional—starting as an engineer, he found his way into hospital administration, and ultimately became a global consultant shaping initiatives like the International Patient Summary. As they dive into his story, Michael reveals the leadership lessons he's gathered along the way, with a strong focus on communication, collaboration, and the value of being a lifelong learner. But beyond the professional accolades, Michael gets candid about something many overlook: work-life balance. He shares how prioritizing personal well-being has been key to his success and longevity in such a demanding field. The episode wraps up with an inspiring conversation about the power of your inner circle—how surrounding yourself with smart, driven, and influential people can shape not just your career, but your entire perspective on leadership and growth. This episode is not just a discussion on digital health; it's a window into the mindset of a leader who's still learning, evolving, and prioritizing what matters most.

Dan Thomson founded Sensay in 2023, a leading platform for creating AI-based digital clones and a pioneer in digital immortality. He founded Sensay to develop solutions across a range of sectors, from healthcare to education, building a knowledge capture and share platform for the betterment of humanity. Dan has a BA in Philosophy from King's College London and an MBA from the University of Cambridge. He has authored two books to date: ‘Immortality in a Digital Age' and ‘The Digital Afterlife'. Summary AI Digital Replicas and Personal Use Michael and Dan discussed Dan's work in AI, specifically on creating lifelike digital replicas of people. Dan explained that this tool is helpful for anyone in business or personal life, as it can draft messages in one's style and voice with their knowledge base. Michael expressed interest in using this technology, noting that it made him think of aspects he hadn't considered before. The meeting was scheduled to last between 20 to 25 minutes. Entrepreneurial Journey and Industry Insights Dan shared his entrepreneurial journey from philosophy to the hospitality industry, including setting up restaurants and bars, before transitioning to tech after a severe concussion. He highlighted the high failure rate and competitiveness in hospitality but praised the industry for fostering hardworking, trustworthy, and creative individuals. Michael acknowledged AI's potential while also appreciating entrepreneurs' humble beginnings. They discussed the value of diverse skill sets and community experiences, like Michael's time at a grocery store, in recognizing people's needs for entrepreneurship. Addressing Memory Loss and Sharing Stories Michael expressed his concern about the loss of memory due to Alzheimer's or dementia and how it affects individuals and their loved ones. He suggested that technology could be used to record and share personal stories and experiences, which would be particularly valuable for those who have lost access to family members due to death. Dan agreed, sharing his own experience of memory loss and how it can be terrifying. He also mentioned that people with degenerative mental diseases are often advised to start a journal or life book to record their stories, but this can be difficult for the elderly. Exploring AI Chatbots for Story Preservation Dan discussed the potential of AI chatbots to learn from individuals and preserve their unique stories and experiences for future generations. He highlighted various use cases: education, preserving legacies, gaming, personal assistance, and brand marketing. Dan also mentioned the technology's ability to extend and empower individuals beyond their physical limitations. Michael agreed, emphasizing the technology's potential to free up time for humans to focus on human-to-human interactions, using Taylor Swift as an example. Embracing AI for Global Collaboration and Growth Michael discussed the potential for increased global collaboration and creativity, particularly in education and technology. He emphasized the importance of not fearing the impact of AI on jobs but rather embracing it as an opportunity for growth and innovation. Michael also shared his personal experience of tracing his ancestry back to the late 11 hundreds, which sparked his curiosity about the lives of his ancestors. He encouraged others to embrace AI and technology's opportunities rather than fearing them. Exploring AI, Legacy, and Family Trees Michael and Dan discussed the potential of using AI and technology to understand our future better and preserve our past. They highlighted the importance of recording personal stories and experiences for future generations despite concerns about privacy and security. Dan emphasized the opportunity to leave a legacy for those curious about our lives and experiences and the potential for future generations to learn from our knowledge and experiences. They also touched on the idea of interactive family trees and the possibility of communicating with ancestors. The conversation concluded with the idea that we live in a "golden age of technology" where we have the tools to record and preserve our stories for future generations. Discussing Data Privacy and AI Character Development Dan and Michael discussed the implications of recording and sharing personal data, with Michael advocating for the greater good and Dan highlighting the potential for misuse. They also touched on the importance of understanding different historical perspectives and the challenges of creating AI characters that reflect diverse personalities. Dan emphasized the potential of their platform to save time and improve efficiency, allowing users to focus on more critical tasks. They concluded by expressing excitement for the future of their project and its potential to revolutionize how people interact with technology. Exploring Sensay's Products and Potential Benefits Michael and Dan discussed Dan's company, Sensay, and its products.   

Brand Experiences, Creative Leadership, and AI with Geoff ThatcherWelcome back to *Your World of Creativity*! In this episode, we are thrilled to have Geoff Thatcher, a creative leader with over 40 years of experience in crafting world-class brand experiences. From Warner Brothers World in Abu Dhabi to the FM Global Center in Singapore, Geoff's projects are renowned globally. Today, we dive into the intersection of creativity and artificial intelligence, exploring how AI is reshaping creative industries and leadership.Geoff's Website Geoff on YouTube @geoffthatcher on Instagram - **AI in Storytelling:** Geoff discusses the dual perspectives on AI—dystopian fears and its role as a storytelling tool. He shares an example of using AI to create personalized songs for a leadership workshop, highlighting its potential to enhance creative experiences.- **Historical Context of Technology in Creativity:** Geoff draws parallels between past technologies like Pepper's Ghost and animatronics, emphasizing that AI is simply the next tool in the evolution of storytelling.- **Universal Languages in Experience Design:** Geoff outlines universal elements in storytelling such as music, geography, time, and light, which transcend cultural boundaries and are fundamental in creating immersive experiences.- **Experience Design Model:** Geoff explains his experience design model: Attract, Trust, Inform, Internalize, and Act. He illustrates its application across various cultural contexts, including powerful examples like the Holocaust Memorial in Washington, D.C.- **Global Collaboration and Future of Creativity:** Geoff expresses excitement about the potential of AI and other technologies to facilitate global collaboration and overcome language barriers, enabling richer creative exchanges and projects.**Key Quote:**"AI allows us to put guests in a story in ways that are so incredibly fun. It's simply a tool to bring people into an experience. We get all hyperventilating about AI, but it's not any different than when they came out with interactive touch screens or 3D film. It's just another arrow in the quiver of experience design."Stay tuned for more episodes as we continue our global journey, talking to creative leaders about their inspirations, ideas, and the confidence to bring their work into the world. Until next time, keep unlocking your world of creativity!

Ever wonder what it's like to practice interventional radiology down under? Dr. Chris Rogan joins us on the BackTable Podcast this week to tell us about his IR practice in Australia, with special emphasis on healthcare system and interventional practice model differences between our two countries. --- SYNPOSIS We cover a wide range of topics, including the differences in IR training pathways between Australia and the U.S., the impact of healthcare models on IR practice, and the cooperation between public and private healthcare. We also highlight the urgent need for more IR specialists in Australia. Additionally, the doctors explore the challenges of public awareness, interdisciplinary and global collaboration, and the ongoing efforts by the Interventional Radiology Society of Australasia (IRSA) to promote IR through public outreach and educational strategies. --- TIMESTAMPS 00:00 - Introduction 04:08 - Australia vs. US Healthcare Systems 08:21 - Compensation and Career Mobility 16:52 - IR Public Awareness and Marketing 25:56 - Global Collaboration and Conferences 30:53 - Travel Tips for Australia --- RESOURCES Dr. Chris Rogan's practice: https://drrogan.com/ Interventional Radiology Society of Australasia (IRSA): https://irsa.com.au/ IRSA 2024 Annual Meeting: https://irsa.com.au/education-events/irsa-annual-scientific-meeting-2024/

Guest: Dalia Najjar, General Manager at Farouk Systems and Social Entrepreneurship Faculty Leader at Al-Quds Bard College for Arts and SciencesOn LinkedIn | https://www.linkedin.com/in/dalia-najjar-ab212643/On YouTube | https://youtu.be/KBwjaHq3G3c?si=uvUt0EkoSGvnF7Y5Hosts: Alejandro Juárez CrawfordOn ITSPmagazine